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ABSTRACT 
BACKGROUND AND AIM 
Background: Human Immune Deficiency Virus (HIV) is a public health challenge worldwide. 
Antiretroviral therapies (ART) are medications that treat HIV virus infection by suppressing the virus 
and stopping progression of HIV disease, and that improve quality of life. People initiated on ART 
need to adhere to their treatment for the rest of their lives. 
In 2016, there were 7,1 million people (age 15-49) in South Africa living with HIV, representing 19 
% of the global HIV burden, with 56% of the adults on ART. Life expectancy of South Africans for 
both males and females improved between 2009 and 2011 because of ART treatment. People lost to 
follow up while on ART compromise their own health and the long term positive benefits of the 
ART regimen, and hence there is a growing emphasis to improve the retention of people who are 
already on treatment.  
Aim:  This study was conducted examining HIV positive South African Clothing and Textile 
Workers Union (SACTWU) members who are currently on ART treatment and had previously been 
lost to follow up (LTFU) from ART care. The study aimed to explore factors associated with LTFU 
of clients on ART treatment and care among the South African Clothing and Textile Union members 
living with HIV and attending the SACTWU Worker Health Program Clinic. 
METHODOLOGY 
An exploratory qualitative study design method was used to explore the reasons why the SACTWU 
union members who are HIV positive and on treatment from their clinic get LTFU. For participant 
selection, purposive sampling was used to recruit the ten patients that had been LTFU and traced 
back to the clinic. These patients had to have been SACTWU members who are HIV positive and on 
ART attending the SACTWU Worker Health Program clinic. Seven service providers employed at 
the SACTWU Health Clinic were also selected for participation in the study. Data was collected 
through a focus group discussion with the service providers, and through in-depth interviews with 
the patient participants. The interviews were transcribed and the content analysed. Data was coded 
and categorized using manual coding. The content of the transcribed and translated interviews was 
analysed thematically and arranged into appropriate themes to generate explanations. 
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FINDINGS 
The study findings showed that factors influencing LTFU were complex and interlinked. The most 
common factors identified as contributing to SACTWU union members getting lost to follow up 
were individual related factors, socio economic factors and health system related factors. The most 
common patient related factors contributing to the SACTWU ART patients being LTFU is non-
disclosure of their HIV status. Non-disclosure resulted in lack of support which led to LTFU. Other 
individual related factors included physical health, lack of treatment literacy, and impact of alcohol 
use, travelling and use of herbal medication as an alternative to ART. Socio economic factors which 
contributed to the SACTWU ART patients being LTFU were cost and logistics, food shortages, 
stigma, discrimination, living conditions of overcrowding and lack of privacy and work related 
pressures. Health system factors that contributed to LTFU among the SACTWU ART patients were 
mostly the required frequent clinic visits and the long waiting times at the clinic. This made a 
noteworthy contribution to the SACTWU union members on ART being LTFU because their income 
was negatively affected by these clinic visits. Other health system related factors included health 
worker attitudes and stand-alone clinics which placed them at risk of potentially been identified by 
others as being HIV positive. 
CONCLUSIONS AND RECOMMENDATIONS 
Strategies need to be implemented that address patient related factors, socio economic factors and, 
most importantly, health system factors. It is hoped a more accepting work environment has the 
potential to make it easier for the SACTWU members living with HIV and on ART to stay adherent 
to the ART treatment and thus reducing LTFU. Engaging the employers will also assist in increasing 
their awareness to HIV/AIDS and will result in special consideration of their employees on ART 
when they have their clinic appointments. Ways to encourage and deal with the possible need for the 
disclosure of HIV status should be pre-emptively discussed with patients before the lay counsellor 
performs an HIV test so that should the patient test positive, potential plans for disclosure have been 
developed.  Patients should be encouraged to be accompanied by the person to whom they have 
chosen to disclose their HIV status when they attend their second scheduled appointment at the 
health facility. They should also be counselled not to stop taking ART if they have been drinking but 
to rather continue even if they have missed some medication doses. They should also be counselled 
not to stop taking ART if they have been drinking but to rather continue even if they have missed 
some medication doses. ART services should be offered at both SACTWU clinics (the stand-alone 
ART clinic and the general PHC clinic) so that a patient who did not wish to be seen as living with 
HIV has the option of obtaining their ART without having to collect this from the ART clinic. 
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CHAPTER 1 - INTRODUCTION 
	
1.1 INTRODUCTION 
Human Immunodeficiency Virus (HIV) is one of the major contributors to morbidity and mortality 
worldwide. UNAIDS (2015) global statistics estimate that there are approximately 36.7 million 
people currently living with HIV globally. Sub-Saharan Africa, and particularly Southern and 
Eastern Africa, is the region most affected by HIV. Sub-Saharan Africa has approximately 25.6 
million people living with HIV (PLWH) comprising 70 % of those living with HIV worldwide 
(UNAIDS, 2015). Globally, as at July 2017, 20.9 million PLWH were initiated on antiretroviral 
therapy (ART). 
Antiretroviral therapy (ART) comprises a combination of medication that provides treatment to 
people living with HIV (PLWH). The drugs do not kill or cure the virus but control viral replication 
within a person’s body and allow the individual’s immune system to strengthen and regain capacity 
to fight infections. When taken in combination, ART significantly reduces mortality and improves 
the life expectancy in PLWH. When virus replication is slowed down, so is HIV-related disease and 
transmission (World Health Organisation (WHO), 2013). Africa is the leading continent in 
expanding access to ART therapy, with Sub-Saharan Africa having approximately 11 million PLWH 
on treatment, and with South Africa having the largest ART treatment program (UNAIDS, 2016). 
South Africa has the largest global ART treatment program with an estimated 3.4 million PLWH 
initiated on ART treatment by mid-2015 (Johnson et al., 2017). Despite the greatly improved 
coverage with ART, significant numbers of people drop out of care at various points of the treatment 
pathway. This reduces the individual and public health effectiveness of provision of ART care 
programs. In 2014, UNAIDS launched a campaign called ‘90-90-90’ for 2020 with the aim of 
controlling and ending the HIV epidemic by the year 2020 (UNAIDS, 2014). This means that by the 
year 2020, 90% of all those who are HIV positive should be diagnosed and know their status, 90% of 
all those who are diagnosed with HIV should be initiated on ART, and 90% of all those on ART 
should be virally suppressed. The currently accepted defines LTFU as a patient having not been seen 
at the clinic either by a nurse or doctor or having collected ART medication at the pharmacy for “90 
days after the last scheduled appointment’’(WHO, 2011: 26). 
http://etd.uwc.ac.za/
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While the access to ART rate has increased in the low resource settings, the retention of patients on 
ART care has become an increasing challenge (Fox & Rosen, 2010). Because of poverty, care to not 
disrupt a person’s employment is frequently prioritized over their own healthcare. Hence, working 
class people may be among those commonly LTFU from ART care (KI, social worker). Many 
strategies have been developed in order to initiate as many people living with HIV (PLWH) as 
possible on ART and reduce the number of PLWH who become LTFU from ART treatment. In 
South Africa, these include free public sector healthcare provision of lifelong ART upon diagnosis 
with HIV since 2016 (Cornell et al., 2017). Other initiatives include increasing availability and 
access to local clinics in the rural areas, ART adherence promoting clubs in the communities and 
establishing Central Chronic Medicine Dispensing and Distribution (CCMDD) programmes and 
workplace programmes. In the case of the latter, those employed can receive medical care at the 
workplace healthcare facility or near their employment (National Department of Health, South Africa 
(DOH, 2015). The trade union South African Clothing and Textile Workers Union (SACTWU) has 
also established clinics where the union members can seek medical services closer to their 
workplace. These clinics were established for the convenience of union members so that their 
employment is not greatly affected when seeking healthcare. 
My research was conducted with the intention to contribute to an improved understanding of the 
factors influencing loss to follow up from ART care among trade union members living with HIV, 
belonging to the SACTWU and receiving ART from the SACTWU clinics. 
 
1.2 PROBLEM STATEMENT 
LTFU of PLWH on ART presents a serious problem for an individual’s health and public health 
initiatives to control the HIV epidemic. Interruption of ART can lead to an individual’s health 
deteriorating and a person may become more infectious as his or her viral load will be high. The lives 
of those living with HIV are at greater risk as they are more likely to contract opportunistic infections 
as their CD4 count decreases. From a public health perspective, poor ART adherence can lead to 
both individual and group resistance to ART medication and greater risk of HIV transmission. Data 
for 18 countries collected in 2013, including a cohort of approximately 200 people on ART in each 
country reviewed, indicated that the average retention rates decreased from approximately 86 percent 
at 12 months on ART to 82 percent at 24 months to 72 percent at 60 months from starting ART 
(WHO, 2013). 
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As a result, there is a growing emphasis on improving the retention of people already initiated on 
ART. Ensuring good adherence will decrease the HIV incidence rates as PLWH are less infectious 
when on ART. Known barriers to adherence to treatment include having to travel long distances to 
the health facilities, long waiting times at these facilities, shortage of clinic staff, PLWH having 
difficulty taking time off work to attend healthcare, inadequate understanding of their ART  
treatment plan and fear of HIV-related stigma, discrimination and death (WHO, 2013). It is therefore 
important to investigate the reasons for LTFU from ART care in order to address problems 
associated with poor ART adherence.  
SACTWU members have their own health facility established closer to the workplace where they 
can collect their ART and receive appropriate specialised HIV care. This means that they do not have 
to attend at their overcrowded local clinics where they could also be seen by other members of their 
community. Nevertheless, some SACTWU members living with HIV on ART are LTFU from ART 
care. Exploring in greater depth the reasons for this will assist SACTWU in developing further 
strategies for retaining and linking their ART clients in care and support the promotion of greater 
treatment adherence. 
 
1.3 STUDY RATIONALE 
Expanding access to ART brings positive changes to the global HIV epidemic in numerous ways. 
Key areas of improvement include PLWH becoming healthier, AIDS related morbidity and mortality 
showing substantial declines, risks of drug resistance being reduced and HIV transmission risks for 
an uninfected partner becoming minimal (WHO, 2013; UNAIDS, 2014). The UNAIDS report (2014) 
emphasises that exploring the reasons patients are LTFU form ART care will help highlight care and 
treatment gaps that need to be addressed so that once initiated on treatment clients are encouraged to  
continue with ongoing treatment. Exploring the reasons patients are LTFU from ART care at the 
SACTWU health clinics may specifically assist healthcare workers at these facilities to develop 
strategies to improve patient ART retention as well as provide lessons for work-place based ART 
programs, more broadly. This will include improving our knowledge of health services related 
factors, patient related or drug (ART) related causes or a combination of causes to LTFU from ART 
care. Better understanding of these reasons causing barriers to retention in care will contribute to 
interventions implemented to ensure that the goal of 90-90-90 is achieved (WHO, 2015). 
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1.4 RESEARCH AIM 
The aim of this study ws to explore factors associated with having been lost to follow up of clients 
on ART treatment and care among the South African Clothing and Textile Union members living 
with HIV and attending the SACTWU Worker Health Clinic in Durban, South Africa. 
 
1.5 OBJECTIVES 
The objectives were: 
1 - To describe the demographic profile of SACTWU Union Members living with HIV and attending 
the union health clinic.  
2 - To explore among the SACTWU members attending at the clinic and on ART, factors that may 
influence LTFU such as economic factors, social and cultural factors and health systems factors that 
may hinder ART care attendance 
3 - To explore facilitating factors that improve retention of members on ART and in care. 
 
1.6 RESEARCH QUESTION 
The aim of conducting this research study was to answer the following questions: 
What are the reasons of loss to follow up of SACTWU Union members living with HIV from ART 
care? 
What are the healthcare providers’ views of the issues clients face in ART adherence leading to 
possible LTFU from the SACTWU ART care? 
 
1.7 CONCLUSION 
The mini thesis consists of six different chapters. In chapter one the background of the research 
study, its context, the research problem, research question and its aim and objectives have been 
discussed. Chapter two reviews literature on the reasons for LTFU from ART care among patients on 
ART. This will assist in informing the exploratory causes for SACTWU members becoming LTFU 
in ART care. Chapter three describes the methodology used. This includes describing the research 
settings, study population, study design, the type of sampling strategy, data collection and analysis, 
http://etd.uwc.ac.za/
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study rigor, research ethics considerations and the study’s methodological limitations. Chapter four 
presents the research findings. Chapter five interprets the research findings and compares the 
findings of the study with those of other studies. In chapter six, I summarize the study implications 
and suggest recommendations, based on the findings. This may assist in developing strategies to 
decrease the number of PLWH in this setting who become lost to follow up. 
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  CHAPTER 2 - LITERATURE REVIEW              
 
2.1 INTRODUCTION 
Chapter two examines the literature in the field focusing on research evidence on factors contributing 
to loss to follow up of people living with HIV while on antiretroviral therapy (ART). In this review, I 
focus particularly on the following influencing factors that have been researched: patient related 
factors and socio-economic and health system related factors. 
 
2.2 DEFINITION OF LOSS TO FOLLOW UP 
A successful HIV program is measured by the lower prevalence of the AIDS-related opportunistic 
infections and mortality rates. This is because of the high morbidity and mortality rates associated 
with the illness, if the person living with HIV is not on ART. In sub- Saharan Africa, services for 
HIV care and treatment have expanded rapidly and have provided life-saving ART to over 2million 
infected adults and children (Chi et al., 2011). It has therefore become imperative to measure 
retention in care, which is measured by loss to follow up (LTFU) to determine the program 
effectiveness (Brinkhof et al., 2009).  
Retention in HIV care can be defined as continuous engagement in care from initial diagnosis with 
HIV in a package of prevention, treatment, support and care services (WHO, 2011). Retention can be 
defined from the moment of initial engagement in care of being diagnosed with HIV and linked 
successfully to services, to assessment for eligibility, initiation of ART and remaining lifelong in 
ART care. This entails patients remaining linked to a facility and religiously adhering to their clinical 
appointments or pharmacy pick up of their ART medication. This is because ART prevents and very 
substantially reduces the risk of opportunistic infections and mortality. LTFU may include people 
who have self-transferred to another facility, unascertained deaths as well as true losses to follow up 
(WHO, 2015; Onoka et al., 2002). For clinical purposes, a shorter period of time has been considered 
as LTFU for patients who have missed clinic appointments, for either a consultation with a nurse or 
doctor or collection of ART medication, as this can lead to ART non-adherence creating individual 
drug resistance. This may result in a broader public health drug resistance problem for the ART 
program. Patie (2015) explains that taking ART is a lifelong commitment that requires the 
individual’s consistent adherence to the prescribed treatment. This is in order to prevent disease 
progression and to promote optimal health. Good adherence to ART prolongs life and improves 
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quality of life so that fewer opportunistic infections are experienced. It is important to establish why 
and how people become LTFU after starting ART. If there is no retention in care of patients on ART, 
then it may be an indication of the failure of the program. 
A challenge to ongoing research on program attrition (absence of retention in care) has been a lack of 
standardised definitions of LTFU. A standardised definition of LTFU is required for comparative 
reviews of data on patient retention to be possible from various ART programs. LTFU and retention 
to care are two different entities that are used to monitor the ART program. These are a direct 
opposite of each other because when you know the retention rate, you indirectly know the LTFU rate 
in a program. In many programs providing ART, clinicians report substantial patient attrition; 
however, there was a lack of clear consensus or uniformity in criteria for defining patient to LTFU in 
studies in the past (Chi et al., 2011).  LTFU was often described as “lateness” for scheduled 
appointments, but the actual time intervals used varied greatly among programs (Chi et al., 2011) 
 A number of time measures were proposed in the medical literature which included late for one’s 
last scheduled appointment, or the time elapsed since the last clinical appointment which was a 
consultation with either a nurse or doctor or pharmacy visit to collect medication. In a cohort study 
conducted in Lusaka, Zambia, patients who were lost to follow up were classified according to the 
following definitions: late for scheduled clinical encounter, which refers to the patient going to the 
clinic to be in consultation with a doctor or nurse or to pick up their ART at the pharmacy (>30, >60, 
.90,>180 and  > 365 days) and time since last clinic encounter with either a health care worker or 
medicine pick up at the pharmacy (>90 and > 180 days) (Li et al., 2013). Other literature, for 
example from Medecins Sans Frontieres (Doctor Without Borders’), has defined LTFU from ART 
care as being more than 2 months late for a scheduled appointment, which was when a patient did not 
return to care for 2 months or longer from their last clinic visit. Yu et al. (2007) in northern Malawi, 
used a 3 month interval from the time of a missed appointment for a clinic visit. Kaloustian et al. 
(2006) describe LTFU as 3 months without the patient being seen from the last clinic visit. In an 
analysis of 19 countries in 2011, Chi et al (2011:10) researchers recommended that the definition of 
LTFU from ART care should apply to a patient who has not been seen by a health care provider or 
has not collected ART medication for 180 days or more since their last clinic visit. While these 
studies added to the field of knowledge in promoting a focus on the importance of retention of 
patients on ART, the differences in their definition make it possible to compare their outcomes and 
to use in other studies. 
The current WHO definition of LTFU for a patient on ART, which reaches a consensus on its 
definition, defines LTFU as a patient having not been seen at the clinic either by a nurse or doctor or 
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having collected ART medication at the pharmacy for “90 days after the last scheduled 
appointment’’(WHO, 2011: 26). Hence, this definition indicates that it is only after this period of 
time has elapsed that a patient should be considered LTFU for the purpose of monitoring and 
evaluation classifications (WHO, 2014). This is now the standard definition for assessing LTFU on 
ART. Monitoring and evaluation of data allows program evaluation and is critical for informed 
decision making for the progress and impact of any program. 
 
2.3 REASONS FOR LOSS TO FOLLOW UP 
Particularly given the rapid expansion of universal access to ART in Sub-Saharan countries it is 
important to conduct studies examining LTFU to care in ART programs. Rosen & Fox. (2011) 
conducted a study examining ART programs in different countries in Sub-Saharan Africa including 
South Africa and Botswana. The study revealed retention rates to be between 46% and 85%. Among 
the causes of poor retention, LTFU was a significant cause at 56% and then death at 40%. South 
Africa had the lowest LTFU rate of 13% and Botswana had the highest LTFU rate at 36% (Rosen & 
Fox 2011). Among the causes of LTFU, death was seen as the major contributor to LTFU. A cohort 
study conducted in Malawi revealed that 50% of the patients that were classified as LTFU had died 
and only 23% were alive and had stopped treatment. The reason for 27% of those LTFU was 
unknown as they could not be traced. Some clients who were LTFU in one facility had collected 
their treatment at another facility. This meant that they were not truly LTFU but rather that there was 
a gap in communication between facilities in the transfer or movements of patients. Similarly, a 
study in South Africa showed that out of the patients LTFU, 25% of those assumed LTFU were in 
fact accessing their treatment at other ART centres (Dalal et al., 2008). In contrast, the United 
Kingdom has had lower rates of clients LTFU due to death. In a cohort study conducted in the 
United Kingdom, only 3% of the patients were classified as LTFU due to death (Gerver et al., 2010).  
The findings of the above studies reveal that death contributes a lot to the incidence of LTFU. These 
figures of those classified as dead could be more if those truly LTFU were found. I can conclude that 
other reasons causing patients to be LTFU could be known, if all the patients who are LTFU are 
found. This still shows gaps in the ART programs. 
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2.4 INDIVIDUAL AND PATIENT-RELATED CHARACTERISTICS AND FACTORS 
ASSOCIATED WITH LOSS TO FOLLOW UP 
Research shows that most of the discontinued care in ART occurs within the first year of initiation. 
Retention of people on ART, and ensuring adherence to treatment are critical determinants of 
successful long term health outcomes for PLWH (Berherto et al., 2014). Despite the proven benefits 
in being on an ART program, patients LTFU remains a major problem. It is therefore important to 
establish why and how people become LTFU after starting ART. 
Research on LTFU of patients in ART care highlights individual characteristics that act as potential 
risk factors associated with LTFU. Analysing the patient characteristics of those LTFU can assist in 
directing the focus to where interventions are needed in ART programs. Most studies conducted in 
the Sub-Saharan African countries have estimated that 20-40% of patients on ART are LTFU due to 
certain characteristics (Berherto et al., 2014). These characteristics include a younger age group 
category (Age 11-19), those who have had a substituted regimen because of regimen failure or severe 
adverse effects, a lower WHO clinical staging, a lower CD4 count and non-isoniazid prophylaxis 
which is used for the prevention of acquiring tuberculosis. A cohort study conducted in Ethiopia 
examining predictors of LTFU in patients on ART revealed that the risk of LTFU increased with a 
decreased CD4 count. In contrast, in Switzerland and Zambia an opposite pattern is seen in which 
risk of LTFU increased among the patients with a higher CD4 cell count (Berheto et al., 2014; Li et 
al., 2013). LTFU among those in Ethopia with the low CD4 count could be from death, whereas 
those in Switzerland and Zambia with the increased CD4 count might have been healthy and decided 
to stop coming to collect their ART because maybe their CD4 had increased drastically. Several 
studies have shown that men are more likely to become LTFU due to morbidity and high risk of drug 
abuse (Li et al., 2013). In a study conducted in India male gender was associated with LTFU 
(Alvarez-uria et al., 2013). Similarly, with Li et al.’s 2014 study in Zambia, men were most likely to 
be LTFU. This was because men tended to fear stigma and were more likely to be involved in habits 
like consuming alcohol which contribute to them being LTFU. Age of the patient also plays a 
significant part. The younger the patient the more likely for them to be LTFU. Li et al. (2013) agreed 
that one of the patient characteristics associated with LTFU was that of a young age. Patients with 
advanced clinical stages (III and IV) were less likely to be LTFU as there was an increase in health 
seeking behaviour. This was because their CD4 count was low and exposed them to feeling sick 
frequently. However, a study conducted among the French showed a history of AIDS defining 
illnesses being associated with greater LTFU (Rosen & Fox 2011). This is because the patients had 
become so ill that they were not able to go seek assistance at health facilities, or it may be because of 
death. Unlike those patients who become worried that they might get ill due to their low CD4 count, 
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others have become already so ill that they do not even have the energy to seek medical assistance. 
Regimen substitution due to adverse reactions to new drugs is also associated with LTFU (Rosen & 
Fox 2011). This is maybe because patients become concerned about the side effects of the new 
drugs, causing them to become LTFU and perhaps seek other treatment options or stop treatment. 
LTFU is also found to be associated with the length of engagement in care. This is an occurrence 
seen globally. Berheto et al. (2014) state that, generally, the possibility of dropping out from care 
gradually increases with being longer in care. 
The studies mentioned above highlight some of the most common patient characteristics of those 
who are LTFU. This could assist ART programs in focussing their efforts particularly on those 
individuals with those characteristics, once initiated on ART and retain them in care thus decreasing 
the rate of LTFU amongst them. Educating the community, especially those prone to LTFU, would 
improve or decrease the rate of LTFU (Berheto et al, 2014). One also needs to take into consideration 
when looking at these studies above, the difference in their settings. Africa and Europe have very 
different circumstances and therefore the health provision will differ. This will inevitably influence 
their LTFU statistics and the outcome of the studies conducted. 
Patient-related factors involve individual influences that affect behaviour towards an illness. These 
include an individual’s access to resources, knowledge, and beliefs towards their health or illness or 
their expectations based on prior visits to health services (Mathebula, 2014). Ahmed et al. (2013) 
state that patients with a better immune status or less advanced disease stages could result in self- 
assessment that they are healthy and therefore not in need of health care. In the recent South African 
national ‘test and treat’ guidelines, large numbers of those testing HV positive are initiated 
immediately on ART, regardless of their CD4 count and clinical staging (DOH, 2015). This means 
that some patients are initiated on ART while still having a very high CD4 count and may not have 
experienced any illnesses related to their HIV status. This could contribute to patients being LTFU, 
as they may see no need to take their ART while their CD4 count is high and they do not feel ill. 
Maskew et al. (2007) mention that patients’ lack of understanding that ART needs to be taken life-
long may contribute to individual ART discontinuation. Mugisha et al.’s (2014) quantitative study 
conducted in Northern Uganda examining 41 health institutions, found that 31 033 of patients who 
had discontinued ART and who were traced through the study, reported they were unaware that ART 
involved life-long treatment adherence. This highlights the need for health providers to emphasise 
the importance of taking life-long ART and the negative consequences of non-adherence to treatment 
once initiated. 
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Side effects of ART have also been found to promote LTFU from ART, especially among those who 
have a tuberculosis (TB) co-infection. Complaints of having a heavy ‘pill’ burden when taking 
combined treatment for TB and HIV have emerged as a negative factor to adherence among co-
infected patients (WHO, 2014). Some drugs cause side effects in patients such as severe diarrhoea 
caused by the Alluvia. This side effect may lead to patients not returning for their medication refill. 
In a study conducted at the Immune Supress Syndrome clinic in Uganda, among 78 interviewed 
patients initiated on ART in the period between January 1, 2004 and September 30, 2007, one of the 
commonest patient-related reason reported for LTFU included ‘feeling too sick’ from medication 
side effects. Miller et al.’s (2010) qualitative research study conducted in Themba Lethu Clinic in 
Johannesburg, South Africa reported similar findings, as one respondent reported: “As soon as I was 
started on ARTs I became so ill and weak and developed a running stomach” (Miller et al., 2010:50) 
This highlights the need for patients to be properly informed about the side effects of their 
medication, so that that they are better prepared for what to expect when starting ART. Some patients 
might be reluctant to start or to continue with their ART because of side effects they have heard 
about from other people. For example, they might have heard of or seen people they know whose 
body shape changed due to taking certain ART medication in the past. During health education and 
counselling emphasis needs to be placed on explaining that newer ART drugs have been developed, 
with less such side effects and that a patient can switch to other medication if they experience side 
effects on those prescribed for them, rather than discontinuing treatment. Patients moved to a fixed 
dose combination (FDC) regimen of ART medication, involving stopping an older drug regimen, 
could also lead to patients’ concern about developing side effects on new regimen, if they do not 
have clear information may contribute to LTFU (Geng, et al.2010). 
 
2.5 SOCIO-ECONOMIC FACTORS 
Socio-economic factors influencing our health attitudes and behaviour are underpinned by the social 
and economic experiences and realities. These mould our personality, attitudes and lifestyle 
(Mathebula, 2014). Economic factors include inability to pay for health service visits, lack of food 
and broader financial difficulties. In a qualitative study conducted in Johannesburg South Africa, one 
female respondent reported “One of the reasons I stopped coming for treatment was because of 
transport cost” (Miller et al., 2010: 51). While South African primary healthcare facilities services 
are free, patients incur costs in public transport travel to get to health facilities. This may hamper 
those who are unemployed or earn low salaries from attend health service. In addition, those who are 
employed may not want to risk losing a day’s pay by having to attend health facility. In Miller et 
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al.’s (2010) study, employed respondents reported difficulties in being able to take off working time 
to attend the clinic during regular operating hours. This was, particularly if they had newly started 
working at a company. Therefore, some patients would be likely to rather miss their clinic visits, for 
fear of losing employment or a partial wage loss. 
Mugisha et al. (2014) adds that food shortages and food insecurity at household level have a great 
impact on adherence and LTFU in the ART program. People who have a chronic condition like HIV 
are routinely advised to practise living a healthy lifestyle, including having a healthy diet. Those who 
are unemployed or without good levels of income cannot afford the expense of healthier food. 
Patients are also informed that they should take their medication after food (KI, pharmacist). This 
may be an additional cause for patients to discontinue their medication, as on certain days they may 
be without food and therefore do not take their medication. 
Stigma is a major barrier to accessing HIV/AIDS services and treatment. Real or perceived 
HIV/AIDS related stigma is a negative response to a person because of their HIV status (Mugisha et 
al.  2014). HIV-related stigma may prevent some HIV patients from disclosing their status to their 
family, friends and employers because they fear rejection or discrimination. They may also avoid 
going to local health facilities for their treatment because they are afraid of being seen by members 
of their communities or families. Some patients fear being questioned by their families about why 
they need to visit a health service on a regular monthly-basis, when it is time for them to collect their 
medication, and this may cause them to become LTFU. 
In some geographical areas, community members adopt alternative therapies and medicines as an 
alternative to starting ART, as they do not feel sick. Remien et al. (2007) suggest that when 
alternative therapies are popular among PLWH, more patients are likely to become non-adherent to 
their ART. Theses alternative therapies include herbs or spiritual therapies. Peltzer et al.’s (2011b) 
study conducted in KwaZulu-Natal South Africa revealed that ART non-adherence was associated 
with the use of herbal treatment (Remien et al, 2007). 
Lack of family support is also a contributor to LTFU among ART patients. PLWH who do not have 
family support may feel unloved and isolated, posing a challenge in ART adherence (Bongololo et 
al., 2005). Support can be closely related to disclosure. PLWH may fear discrimination from their 
spouse, social network, and other family members and therefore not disclose their HIV status and 
end up with no support. Moomna’s (2012) study in Zambia among PLWH similarly showed that 
patients who disclosed their HIV status to families and friends experienced support and fewer 
challenges in adherence to ART, in contrast to those without social support. 
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2.6 FACTORS RELATED TO THE HEALTH SYSTEM  
Health institutions’ service delivery problems, such as long waiting times, may contribute to patients 
becoming LTFU from HIV care in developing countries (WHO, 2009). A lack of understanding on 
the part of the patient and/ or the inadequate provision of information by healthcare workers can 
contribute to clients being LTFU. The newly introduced ‘test and treat’ HIV guidelines in South 
Africa have led to a much larger number of patients being enrolled in ART programs. This could 
exacerbate overcrowding in health care centres, which would mean that the health care providers 
have limited time available to attend to patients. Health provider illness due to high burden of 
patients for whom they need to care may have led to more staff falling ill or becoming fatigued and 
having to take time off work (Mugavero et al, 2010). This in turn means that facilities are often short 
staffed and not all patients can be attended to. This may lead to some being turned away without their 
tablets. Mugavero et al. (2012) report that workforce shortages have increased due to insufficient 
numbers of qualified clinicians specialised in HIV care and treatment to accommodate caring for the 
growing numbers of patients on ART. 
Miller et al’ s. (2010) study reported health service related factors for discontinued clinic attendance. 
As one woman reported: “I lost my card and I was afraid to come to the clinic…isn’t it that at the 
reception when you have no card they tell you to go back” (Miller, 2010:50). If the procedure had 
been properly explained to her, she may not have assumed she would have been chased away and 
became non-adherent to treatment. An India study showed that some patients were LTFU because of 
fears of harsh treatment they may receive from health care workers (Alvarez-uria, et al., 2013). 
Training of quality of care in health care providers’ attitudes is vital, as negative attitudes can 
contribute to clients being LTFU. 
Inflexibility in clinic hours to accommodate work schedules and domestic care activities may also 
serve as barriers to consistent HIV care attendance (Mugavero et al., 2012). Adherence to ART 
means regularly keeping all HIV care scheduled appointments. Health facilities often function only 
during weekdays, when most people are at work and may find it inconvenient to attend services 
during the week. This may be a contributing factor to LTFU of some patients, as they need to choose 
remaining at work over attending the clinic. 
With major increases in patients initiating ART in South Africa, there have been drug shortages or 
stock outs in some health institutions. For example, Themba Lethu clinic at Helen Joseph Hospital in 
Johannesburg sees more than 800 HIV/ AIDS patients weekly. This may be partly due to collecting 
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ART medication at a hospital being preferred by some patients because of a number of local clinics 
experiencing drug stock outs and shortages. One patient cited “sometimes they say there are no pills 
and send me to the hospital” (Miller, 2010:51). This could contribute to patients becoming LTFU, 
because they may be discouraged from going to the same health facility again if they find they have 
to return home without their medication because of drug shortages.  
From the reasons that contribute to LTFU mentioned in the studies above, one can conclude that all 
the influences on becoming to LTFU are interlinked. A public health approach which needs to be 
employed in order to manage a successful ART program. A public health approach focuses on 
preventing health problems in a way that extends better care and safety to the entire population rather 
than individuals. An ART program should not only focus on the ART drugs, side effects, stock 
available, resistance and retention rate, but also take into consideration the issues around the 
individual which could make it difficult for them to commit to care. 
 
2.7 CONCLUSION 
The increasing proportion of patients’ LTFU while on ART compromises their own health and the 
long term success of the ART program. It impacts negatively on the immunological benefits of ART 
and increases the probability of AIDS-related morbidity, mortality and hospitalisation for 
individuals. The broader consequences of treatment failure due to poor adherence also lead to ART 
drug resistance at a population level (WHO, 2014). Based on the literature I have reviewed, a 
complex diversity of barriers has been found to contribute to becoming LTFU among patients on 
ART. 
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  CHAPTER 3 - RESEARCH METHODOLOGY 
 
3.1 INTRODUCTION 
This chapter describes the methodology used in this study. It details the study setting, study 
population, study design and the sampling technique used. It describes the data collection methods 
used and the analysis of the data, efforts to address credibility, rigour and trustworthiness, and also 
the methodological limitations of the research and the research ethics considerations.                     
   
3.2 THE STUDY SETTING 
The South African Clothing and Textile Workers Union (SACTWU) is one of the largest unions in 
South Africa. It has developed health facilities for its members in various parts of the country. This 
study was conducted in one of the SACTWU clinics in KwaZulu-Natal, in the Ethekwini district. 
The clinic is in an industrial area of the Durban metropolitan area where most of the clothing and 
textile factories are situated. It was established in an industrial area so that SACTWU members 
would be able to receive medical assistance not too far from work. This allows them to collect their 
medication during their lunch hour. Some factories have allowed their employees a certain amount of 
time off to go to the clinics and still get their full working day’s pay. SACTWU also has a number of 
panel doctors distributed around Ethekwini, to whom those members who work outside of the 
Durban metro can go to seek health services. They obtain care at selected practitioners, at no extra 
cost. The clinic offers HIV care including ART treatment, tuberculosis screening and treatment and 
primary health care services to SACTWU members from areas around the Durban metropolitan area. 
Currently, the clinic has 1560 clients on ART and this number has been increasing rapidly since the 
introduction of the South African ‘test and treat’ national guidelines. The majority of the population 
attending the clinic is Zulu speaking, with a minority group, English-speaking. The SACTWU 
members earn a low income via weekly wages but have access to free health services throughout the 
union clinic facilities as long as they remain union members and pay the SACTWU levy. The clinic 
operates from Mondays to Fridays, between the hours of 6:30 and 15:30. The clinic opens as early as 
possible so that patients are attended to before going to work. This allows the clinic to attend to as 
many of the members as possible, so they can get to work on time and not lose their day’s pay.	The 
clinic has a medical practitioner, two professional nurses, two lay counsellors who do HIV 
counselling and testing and conduct ART literacy classes for those who have tested HIV positive, a 
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social worker, two pharmacists and two pharmacy assistants. It also has a home based care program 
in which community carers go out to the patients’ homes to conduct home visits when necessary. 
The community carers together with the social worker also do the tracing of clients that are LTFU. In 
addition, the clinic has a team of lay counsellors involved in an outreach program, who periodically 
visit all factories which are serviced by this clinic. During the outreach program, they offer HIV 
testing and counselling to the workers and refer those who are HIV positive to the clinic for HIV 
care. 
 
3.3 THE STUDY DESIGN AND METHODS 
The study used exploratory, flexible qualitative design. This type of study is useful to generate in 
depth insight into barriers that lead to clients becoming LTFU and to potential facilitators to 
remaining in care. A qualitative research approach helps uncover concepts which can help in 
understanding the perceptions, experiences or behaviours of people and their social meanings (Pope 
& Mays 1995).  According to Black (1994), qualitative research assists in exploring issues in depth 
rather than in measuring them or associating them with other variables, as is the case in quantitative 
research. Qualitative research is especially effective in obtaining culturally specific information 
about people’s values, opinions, behaviours, relationship-related and the social contexts of that 
particular population (Mack et al., 2011).  
The strength of qualitative research methods in exploring the reasons for LTFU from ART care is its 
ability to provide complex textual description of how people experience or feel about their being 
LTFU or discontinuation on ART. It is suited to the research objectives of revealing the individual, 
socioeconomic and health service related aspects of LTFU of patients on ART, and investigating 
client and providers’ feelings and perspectives on health care centre services, including those 
provided at the SACTWU worker health clinic. It asks the questions why and how events occur. 
According to Mack et al. (2005), qualitative methods are also effective in identifying intangible 
factors such as social issues which may not be readily apparent in the type of questions asked in 
quantitative research. Qualitative methods allow flexibility, meaning that they allow greater 
spontaneity and adaptation to the interaction between the researcher and the study participants. 
Participants have the opportunity to respond more elaborately and in greater detail and depth. 
Its use of open ended questions and probing gives participants the opportunity to respond in their 
own words, rather than restricting their choice to fixed responses, as would be the case in 
quantitative methods. Open ended questions have the ability to evoke responses unanticipated by the 
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researcher (Brink 2006). Qualitative research is therefore well placed to seek to understand the 
factors underpinning the problems of patients becoming LTFU from ART, from the perspective of 
those affected. 
 
3.4 POPULATION AND SAMPLING 
3.4.1 The study population 
The study population in this research comprised SACTWU members on ART attending the 
SACTWU Worker Health Programme Clinic in Durban, South Africa. This included men and 
women working in the clothing and textile industry and aged of 18 years and above. The study 
population work and live in different parts of the Ethekwini Municipality. It included 12 SACTWU 
members that were previously LTFU from ART from the SACTWU clinic for more than six months 
and had since been traced or returned for treatment. This group of patients was considered as an 
appropriate study population from which draw the sample as they would provide rich information on 
why they were lost to follow up. They had not returned voluntarily but has been followed up by 
clinic staff and agreed to return. It would have been very difficult to locate members who had 
permanently been lost to follow up from ART care as many moved from their original address and 
were often no longer working in the industry. 6 Key informants were also interviewed in the research 
study. Key informants consisted of health care providers who work at the SACTWU ART clinic. The 
SACTWU clinic has a total number of 14 health care providers. They included a nurse, lay 
counsellors, the social worker, a pharmacist, a pharmacy assistant and community carers who dealt 
with those SACTWU members who were previously lost to follow up. 
 
3.4.2 The Sample selection and methods 
According to Robson (2010), a sample is a selection of a group from a population. Sampling is 
important as it is difficult in research to obtain a whole population for interview. Purposive sampling, 
conventionally used in qualitative research, was used. Robson (2010) mentions that the principle of 
selection in purposive sampling is that the researchers’ sampling judgement should take into account 
typicality or those most likely to provide well informed views on a topic, such as key informants.  
This study sample consisted of ten clients who had been LTFU and subsequently located and had 
returned to care and ART after initially being classified as LTFU. The clinic has a good data base 
system in which clients who are on ART are flagged for attention if they have missed their 
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appointments. After explaining the purpose of the study and the criteria for patients eligible for the 
study to the social worker, the lay counsellors and the community carers, they used the clinic data 
base to help the researcher to identify those patients who were eligible as potential study participants. 
Follow up appointments were made for patients for their collection of ART, but who had previously 
missed appointments in the past as per criteria for LTFU, were identified so they could be 
approached to participate in the study. Those who were interested were provided with a study 
information sheet (Appendix 2A and Appendix 2B…) and those consenting to participate in the 
study were asked to give written consent (Appendix 1A and Appendix 1B) as proof of their 
agreement to participate in the study. 
The researcher also approached potential key informants for study participation. The aim of the study 
was fully explained to them and written consent obtained from those who agreed to participate in the 
study. 
3.4.2.1 Inclusion criteria-patients 
Patients eligible for inclusion in the study were: 
SACTWU members who: 
1 - Had been lost to follow up from ART care for more than three months and found again and 
returned for HIV care and ART. This is because the recognised definition of LTFU stipulates that 
these are clients who have not been seen for three months or more. 
2 - The participants had to be 18 years or older. This is because people who are employed are usually 
18 years or older and hence it would be rare to find participants younger than 18 years in 
employment. In addition, caregiver permission would be needed for participation of those younger 
than 18 years, which would have been difficult to obtain because of issues related to confidentiality 
and disclosure of a person’s HIV status. 
3 - Participants had to be SACTWU members. This is because the clinic is only available to 
SACTWU members. 
4 - Participants must have been receiving ART from the SACTWU clinic. 
 
3.4.2.2 Exclusion criteria 
Patients excluded included those: 
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1 - Less than 18 years of age. 
2 - Not a SACTWU member. 
3 - Had been LTFU less than 3 months. 
4 - Not yet on ART. 
5 - Too ill or incapacitated to be able to be interviewed. 
 
3.4.2.3 Inclusion criteria-key informants 
 
Key informants 
1 - Had to be employed in the SACTWU worker health program clinic, as this would mean they 
would have knowledge and experience of working with the SACTWU members. 
 
3.4.3 Participant recruitment 
When the selected participants came to the health facility for the scheduled appointment, I then had 
the opportunity to explain the research, discuss possible participation with the patient and inform 
them on what basis they had been selected for possible participation in the study. If the patient 
agreed to participate in the research, they signed a study consent form and an appointment for the 
interview was set up. If the patient was not rushing away at the time of their consultation, the 
interview was conducted on the same occasion as their consultation visit. 
Those invited to be potential key informants study participants were provided with participant 
information sheet (Appendix 4A and Appendix 4B) and a confidentiality binding form (Appendix 
3A and Appendix 3B) as these interviews were conducted in focus groups. Health care workers who 
agreed to participate in the study were then given consent and confidentiality binding forms to sign 
(appendices 4A and4B). 
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3.5 DATA COLLECTION 
Study instrument piloting and data collection 
A pilot study was conducted with people who would have been eligible as participants in order to 
determine whether the questions in the interview guide were structured in an appropriate manner for 
responses. The pilot study interviews were excluded from the main study.  
Data for patient participants, who have been LTFU in the past, were collected through semi-
structured individual in depth interviews. Focus group discussions were held with the key informants 
comprising health care workers working at the SACTWU worker health programme clinic. 
Individual interviews were conducted in the language that the participants were most comfortable in, 
which was mostly in isiZulu. This was to ensure that participants could easily express themselves 
comfortably and fluently. The focus group interviews were conducted in English to accommodate the 
non Isi-Zulu speaking individuals. Those health care workers who were not completely fluent in 
English were advised to inform the researcher if any questions were unclear clear, so that they could 
be translated into isiZulu. They were additionally informed that if they felt unable to express 
themselves well enough in English, they could express themselves in isiZulu as the researcher is 
fluent in both isiZulu and English. This proved not necessary after all as they could all respond 
appropriately in English. The interviews were conducted by myself, as the researcher, and were 
audio taped with the consent of the participants. This was to ensure that no information was missed 
and the researcher would be able to go back and listen to the recordings again after the interviews 
were transcribed. My own personal research journal was kept and used while collecting the data to 
note down ideas and themes that emerged. 
3.5.1 Individual Interviews 
This is one of the most common qualitative exploratory research methods instruments. They are 
effective in giving a ‘human face’ to research problems, especially when they are used in dealing 
with sensitive issues like HIV (Mack et al., 2005). The interviews were conducted face-to-face 
individually by me as the researcher, to ensure that each participant felt comfortable and free to 
express their views and individual reasons for having been LTFU. This technique was intended to 
elicit a vivid picture of the participant’s perspective on the research topic. The client was able to 
enlighten the researcher as to why they became LTFU after they started their ART. The client was in 
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a close one-on-one conversation with the researcher during the interview, so the researcher could 
pose questions in a casual manner, listen attentively to the participant’s response and be in a position 
to ask follow up questions and probe the responses. The interviews were conducted at the SACTWU 
clinic in one of the consulting rooms. 
 
3.5.2 Focus Group Discussions 
A focus group discussion involves one or more researcher and several participants meeting as a 
group to discuss a topic (Mack et al., 2005). Focus group discussions are appropriate when a 
researcher can gather together approximately eight to ten participants who feel free to share their 
views on a non- personal topic. In this study, the focus group included the healthcare providers 
mentioned in section 4.3 table 2. They were not asked personally sensitive questions, but rather 
asked about their clients’ experiences. I approached potential providers in a group to ask if they 
would be willing to participate in the focus group discussion and led the discussion, asking the 
informants to respond to open-ended questions. I took into consideration the different ranks of health 
care workers involved in the focus group. If some members of the group appeared to be constrained 
or intimidated to talk in front of those with a higher occupational rank, I had made contingency plans 
to conduct a separate discussion group to cater for them. This was not needed as the group members 
were comfortable engaging with one another. 
 
3.6 DATA ANALYSIS 
In qualitative research studies, data analysis is ongoing, with insights emerging through an 
interactive process during research (Henning, van Ransburg & Smit, 2004). Data analysis started in 
parallel with data collection. The thematic analysis was used analyse the data. The five steps of 
thematic analysis described by Pope, Ziebland and Mays (2000) were followed, namely 
familiarisation, identification, indexing, charting, mapping and interpretation. Familiarisation 
included listening to the recorded interviews, reading my transcripts and studying my notes. 
Identification included identifying concepts and themes and identifying the key issues from the data. 
Indexing was applying the thematic framework by creating codes on the transcript. Charting 
involved rearranging data to fit into appropriate themes to which they relate to and forming charts. 
Mapping and interpretation includes using the charts to define concepts and finding association 
between themes. Once interviews had been conducted the researcher spent time transcribing and 
translating the individual in depth interviews from isiZulu into English. During transcription, 
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pseudonyms were given to each participant rather their proper names being used. Time was also 
spent listening to the tape recordings several times to ensure all information was properly 
documented and nothing was missed. This also assisted in further familiarising me with and 
immersing me in the data.  
Data was coded manually using a coding list that I developed, based on the questions in the question 
guide (see Appendix 5 and 6). The coding list is lists of codes that are I had generated that include 
data with similar extracts. Themes were then identified from the coded data. This involved arranging 
data according to appropriate themes to help generate explanations or interpretation of the data. I 
used the emerging themes to highlight the contributing factors to clients LTFU from ART care and 
potential facilitating factors that may have helped them return to ART care. My research journal was 
reviewed during data analysis to make me aware of my own ideas and beliefs in complementing the 
interview data. 
 
3.7 RIGOUR 
Rigour was ensured during the research process, including data collection and analysis. 
As part of ensuring rigour, a Member checking technique was used to achieve trustworthiness. In 
this method, the validity process shifts from the researcher to the participants in the study (Cresswell 
& Miller, 2000:127). This involved, in addition to recording interviews, summarizing from memory 
what participants had said during the interview at the end of each session and checking that they 
agreed with what I had heard. My MPH mini-thesis supervisor independently coded a few interviews 
to compare her extraction of themes with mine. 
 
Triangulation of data and resources was carried out. This consists of using more than one method of 
data collection during the research process (Robson, 2010). In this study, data was collected from 
two sources through in-depth interviews from the participants who were LTFU and from the key 
informants in a focus group discussion. In addition, as explained, I augmented this data with my 
journal notes. Hence, source triangulation of data also increased the rigour of my study. 
 
Transferability involves describing the background, setting, population, selection and 
characteristics of participants and the themes that emerged from a qualitative study in rich detail, 
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using thick descriptions (Cresswell and Miller, 2000). The thick descriptions of the study methods 
and findings aim to provide the reader with a sense of the exact methods used and events described 
and experienced in the research. This may enable insights to be gained if other settings and similar 
studies were to be conducted for comparability. 
  
Reflexivity: I am a medical officer by qualification, and while I acknowledge the importance of HIV 
cares, I am aware that I have certain perceptions and that clients may have had particular perceptions 
of me as one of their healthcare providers while I conducted this research. While conducting the 
research I kept a notebook of feelings, ideas, personal thoughts, problems and frustrations throughout 
the research process. I referred to these during the write ups of the research and also for monitoring 
my personal ideas, feelings and how I perceived participants to have interacted with me. 
Nevertheless, my position as a healthcare provider at the clinic raises issues of possible bias in 
patient participant responses and reactions to me in my role as a medical officer, as well as the 
healthcare providers’ responses to me as the clinic manager. This may have biased the way they 
answered questions, as they may have wanted to answer in a socially desirable way. The participants 
previously LTFU could also have felt constraints in making comments to me on how they felt about 
the services provided by the facility and could therefore not be a true reflection. 
 
3.8 RESEARCH ETHICS CONSIDERATIONS 
Research ethics approval was granted by the University of the Western Cape Biomedical Ethics 
Research Committee (Appendix 7). Permission and clearance to conduct the research was obtained 
from the SACTWU as well as permission obtained to use their clinic data-base in order to identify 
potential participants for the study (Appendix 8).  
The three fundamental principles of human research ethics were followed. These included that the 
aim, objectives and purpose of the study were fully explained to the study participants before data 
collection began. Participation in the study was voluntary for clients that were LTFU and the key 
informants. I emphasized that potential participants could choose not to participate at all, withdraw 
from the study at any point or decline to answer specific questions. They were assured that a decision 
not to participate or to withdraw from the study would not affect their care at the clinic or affect them 
negatively in any other way. An information sheet explaining details of the study, including the 
benefits and risks was provided to the participants and translated into isiZulu for those who were 
non-English speaking (See Appendices 2A and 2B). Written informed consent was obtained from all 
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the participants and interviews were not conducted without them signing an informed consent form 
(See Appendices 1A and 1B). I included an additional confidentiality binding form for the service 
providers involved in the focus group discussion (FGD) to sign and these too were translated into 
isiZulu (See Appendices 3A and 3B). The participants were assured of confidentiality through their 
consent form being stored separately from the interview data in a locked cabinet and would only be 
seen by the researcher. Anonymity was maintained in reporting of results. Study participants were 
given a study identification number rather than their name being recorded, and pseudonyms have 
been used in writing the reports. General findings reflective of themes that emerged are reported 
rather than findings attributable to specific individuals. 
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CHAPTER FOUR – PRESENTATION OF FINDINGS 
	
4.1 INTRODUCTION 
This chapter presents the findings, from the in-depth interviews with the SACTWU clinic patients 
who had become lost to follow up on ART and from the focus group discussion with the SACTWU 
clinic healthcare worker key informants. I provide details on the socio-demographic characteristics of 
the patients interviewed and the background and the details of the health care worker key informants. 
I describe the factors that hindered patients in remaining in ART care. These factors are grouped into 
individual related factors, socio-economic factors and health system factors. 
 
4.2 SOCIO-DEMOGRAPHIC CHARACTERISTICS OF PATIENT PARTICIPANTS 
A total number of 12 patient participants who met the study inclusion criteria were interviewed. 
Their socio-demographic characteristics are described in Table 1 below. 
 
Table 1 - Socio-demographic profile of patient participants 
Characteristics		 Variables	
Freq.	
n	
Sex	 Male	 5	
	
Female	 7	
Age	 18-25	 1	
	
26-30	 2	
	 31-40	 7	
	 41-50	 2	
Marital	Status	 Single	 7	
	 Married	 4	
	 Divorced		 0	
	 Partner	died	 1	
	
None	 0	
Level	of	education	
Primary	school	
Completed	 2	
Not	completed	 0	
	
Secondary	school	
Completed	 8	
Not	Completed	 2	
	 Tertiary	school	 0	
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4.3 DESCRIPTION OF THE KEY INFORMANTS (KIs) 
A total number of seven health care workers participated as key informants in the focus group 
discussions. Table 2 below shows their socio-demographic profile. 
 
Table 2- Socio-demographic profile of key informants (KIs) 
Characteristics		 Variables	
Freq.	
n	
Occupation	 Professional	nurse	 1	
	 Lay	counsellors	 1	
	
Social	 1	
	
Pharmacist	 1	
	 Pharmacy	assistant	 1	
	 Community	carers	 2	
Gender	 Male	 0	
	
Female	 6	
Race	 Black	 5	
	 White	 1	
 
 
4.4 INDIVIDUAL RELATED FACTORS   
The key individual, or patient, factors which were reported as influencing SACTWU ART patients in 
becoming lost to follow up were non-disclosure of their HIV status; not experiencing ill health; poor 
understanding of their ART treatment regimen; alcohol use; alternative use of traditional herbal 
treatment rather than ART; and unplanned or unanticipated extended travel. These factors frequently 
interacted with each other in impacting on patients’ ability to adhere to treatment and continue 
attending the SACTWU ART clinic. 
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4.4.1 Disclosure 
Lack of disclosure of HIV status hindered ART adherence 
There was consensus among the health care workers interviewed that patients’ non-disclosure of 
their HIV status to close family/friends or a partner acted as a barrier to ART adherence. This 
contributed to SACTWU clinic patients becoming lost to follow up from ART. They were unable to 
call on the support from significant others in their lives in taking their medication or to enlist their 
support in collecting their medication at the clinic if they were unable to collect it themselves. As one 
KI informant expressed this: 
 
‘Having not disclosed their HIV status to anybody caused a lot of the patients to get lost to 
follow up because it eventually becomes difficult for them to collect their medication all the 
time without support and led to some of them being lost to follow up’ (KI, lay counsellor). 
 
Participants frequently found disclosing their HIV status to others difficult, either due to  being 
reluctant to disclose their status altogether or fearing that if their status became known, this would 
become common knowledge outside of their immediate circle of colleagues. This made it difficult to 
openly adhere to their ARV treatment and hindered them from attending the ART clinic to collect 
their medication. As some participants stated: 
‘I stopped coming to the clinic because my mom was asking me why do I have to go to the 
clinic all the time. I have not told her about my status. I realised that this was affecting me so 
decided to stop going to avoid all these questions’ (Participant 4, 38 year old male).  
‘I stopped coming to the clinic because there was a lot of people (work colleagues) who knew 
me (at the clinic) and they have would have told others that we work with that I am also HIV 
positive and so decided to stop coming to the clinic because I was not ready for people to 
know that I also attend the SACTWU ART clinic’ (Participant 7, 41 year old female). 
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4.4.2 Not yet experiencing physical illness can affect perceptions on the need to be on ART 
Lack of experience of physical illness increases the likelihood of patients becoming lost to follow up 
Individuals who had not yet experienced physical illness as a result of their HIV infection found it 
difficult to accept their diagnosis of being HIV positive. This emerged as an important ‘disincentive’ 
to continue with, and be consistent in, ART adherence. Patients felt reluctant to continue taking ART 
when they were not feeling any of the effects of ill health. This in turn influenced clients in becoming 
LTFU from the ART clinic. As one client expressed this: 
 
‘Mina (me) HIV positive? Hai I did not believe cos (because) I wasn’t sick at all. I took 
amaARVs anyway cos (because) I was told my CD4 results are too small. Sometimes I take 
the medication and eventually stopped going to the clinic because I didn’t have time and I 
don’t believe I need them. I stopped going to take my ARVs because I wasn’t feeling sick at 
all’ (Participant 3, 39 year old male). 
A participant who had undergone an HIV test because the opportunity to do so had presented itself 
but had not experienced ill health from being HIV positive and on diagnosis was initiated on ART 
stated: 
‘I was told I have to take ARVs for life, I stopped because I was not sick and taking 
amaphilisi (pills) every night is not nice so I stopped taking them and stopped going to collect 
them’ (Participant 10, 52 year old male). 
 
4.4.3 Treatment literacy 
Lack of treatment literacy hindered adherence 
During literacy ART classes, before the patients are initiated on ART, sufficient information appears 
to be provided to the patients with regards to ART treatment. However, lack of understanding and 
knowledge among some of the patients was still seen to be a problem, despite the view that adequate 
information had been provided. Lack of understanding as to why ART should not be discontinued 
once initiated and needed to be taken for life, made it more likely that patients would become LTFU. 
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‘Work was very very busy and my supervisor shouts cos (because) I have to come to the clinic 
and collect my tablets. So since I was healthy and my last CD4 count was high, I stopped 
attending at the clinic’ (Participant 4, 38 year old male). 
‘I did not know that ARVs were taken for life and I did not get affected on the days I did not 
take them so eventually I should not continue taking the ARVs because im fine’ (Participant 8, 
31 year old female). 
Key informants added that some patients had asked them when they would be able to stop taking 
their medication and be discharged from ART. Hence, misconceptions related to lack of 
understanding were seen as a reason why a number of patients became LTFU. 
‘This one client said he thought you stop ARVs when you feel fine and get discharged’ (KI, 
professional nurse). 
 
4.4.4 Alcohol abuse 
Excessive alcohol use hindered adherence 
Consuming excessive alcohol emerged as a factor that led to patients forgetting to take their 
medication, and contributed LTFU from treatment. Those who consumed alcohol reported that they 
found they did not have time to think of issues such as taking their ART medication on a number of 
occasions due to alcohol consumption; they began to miss taking their medication as they did not see 
the point of continuing to take ART. As a result, they stopped attending the clinic to collect their 
medication. 
‘Angeke ngiqambe amanga (I won’t lie)….on weekend I drink and have party with my friends 
and forget to take my medication and in the end I had missed so many tablets I decided to 
stop because I did not get sick since I was not taking them’ (Participant 7, 42 year old 
female). 
‘Drinking I would say contributed a lot in me deciding to stop my ARVs’ (Participant 12, 25 
year old female). 
Key informants concurred that patients who consumed excessive amounts of alcohol, deprioritised 
coming to the clinic for their ART, and had been more likely to have become lost to follow up from 
the clinic. As one key informant reported: 
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‘Majority of the patients that were normally traced (due to having become lost to follow up 
from the clinic) have drinking as problem that contributes to them being lost to follow up’ 
(KI, Social worker). 
4.4.5 Travelling 
Unplanned or extended travel due to work or visiting relatives hindered adherence 
Participants whose work involved frequent travelling that was often unpredictable in terms of the 
time it would take to cover the required distance, reported that this resulted in them having 
difficulties with ART adherence. This made it more likely that they might become lost to follow up 
from ART clinic. 
 ‘I am a driver at work and so sometimes I travel long distances and find myself not back on 
time for my clinic appointment and my ART run out eventually it made me get used to not 
having the ARVs and ended up not going back to collect’ (Participant 1, 34 year old male). 
‘Travelling eventually made me forget about my clinic appointments’ (Participant10, 52 year 
old male). 
Some participants reported that travels to visit family or friends that were either unplanned, or 
planned but extended unexpectedly, led to them running out of ARV treatment and missing their 
clinic appointments for a medication refill.  
‘I had to go to the farms because my mother-in-law was sick and had to go look after her and 
ran out of medication and since I was not going back I just decided to stop and not go back to 
the clinic and beside my mother–in-law would question me all the time I have an 
appointments at the clinic’ (Participant 3, 51 year old female).  
 Key informants stated that patients who travel a lot were informed of their in case of 
extended travel. They could seek treatment at the nearest clinic where they were located and receive 
their supply of ART instead of discontinuing treatment and eventually becoming LTFU. 
‘It is always explained to the patients that if they happen to be travelling and they run out of 
their medication they can go to the nearest clinic where they are and request for ART. They 
can just take their empty containers and their carrier cards as proof but instead they just give 
up and forget about coming back to the clinic when they are eventually back for a short 
while’ (KI, pharmacy assistant). 
                 
http://etd.uwc.ac.za/
	31	
	
However, there seemed to be a continuous disjuncture between the information that healthcare 
providers reported providing to clients in this regard and clients’ actions while away from their usual 
medication pick up services. 
 
4.4.6 Alternatives to ART 
Traditional herbal medication use 
The use of traditional herbal remedies to treat illnesses is very common among some segments of 
African society. Traditional herbal medications have been advertised to communities and sold and 
promoted as alternatives to ART in treating HIV. Herbal medication is believed by those who 
promote the medication to have the capacity to boost the immune system of the body. Most of the 
participants in the study who had become lost to follow up because of circumstances such as being 
unable to take time off work used traditional herbal medication as an alternative. Traditional 
medicine became more convenient to use than ART because of easy accessibility and because the 
need for collection was less frequent. 
‘I was told that the muthi is for all diseases and HIV and it heals it so there was no need for 
me to collect the ARVS’ (Participant 10, 52 year old male). 
‘I can go to the traditional healer over the weekend when I am not working to get my 
medicine, akuhluphi (it’s not a problem) I am not affected at work and the muthi does heal 
HIV so I forgot about the clinic’ (Participant 9, 55 year old female). 
4.5 SOCIO-ECONOMIC FACTORS 
In this study, key socio-economic factors which emerged as contributing to clients becoming lost to 
follow up from the ART clinic included: costs and logistical issues, food shortages, stigma, 
discrimination, living conditions and workplace attitudes. 
 
4.5.1 Costs and logistics 
Cost and logistical problems contributes to loss to follow up from ART 
Costs incurred when workers became unemployed, and logistical issues related to workers taking 
time off work were identified as some of the reasons why the SACTWU clinic patients became 
LTFU from treatment. The SACTWU clinic is situated near the clothing factories. This is aimed at 
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assisting workers in decreasing their costs in reaching the clinic and easing any logistical problems 
they may face when having to seek medical help. When an individual becomes unemployed they are 
given a period of six months to continue attending the clinic without paying a fee before they are 
transferred out to their local public sector clinic. This is to allow for the individual to have continuity 
in where they attend healthcare in case they find employment again at another factory in the clothing 
and textile industry. Should this be the case, they would then be allowed to continue using the 
SACTWU ART clinic services. However, when an individual continued unemployed it became 
difficult for them to incur the cost of travel to the SACTWU clinic as they had no income over this 
period and were also constrained by having to spend time trying to find new employment.   
‘While I had no work, I had no money and I stopped coming to the clinic because I was 
looking for job in the other factories’ (Participant 12, 25 year old female). 
Key informants concurred, saying: 
‘Most of the factories are near the SACTWU clinic and so those who become unemployed 
find it hard to come to the clinic because they cannot afford bus fare to get to the clinic’ (KI, 
social worker). 
 
Some participants complained that even when employed, because they are paid on the basis of the 
number of hours worked, taking time off work go to the clinic meant they earned less income, 
placing a strain on their financial situation. It therefore became difficult for them to lose out on part 
remuneration in order to keep their clinic appointments. This acted as a deterrent to maintaining their 
regular ART clinic appointments. 
‘I cannot afford to keep taking time off to come to the clinic ngoba (because) I will be paid 
less hours, meaning less money all the time I come here. That’s why is stopped going because 
they won’t even allow me to send someone to collect on my behalf [Meaning that the clinic 
does not always allow patients to send someone else to collect their treatment on behalf due 
to the need to review their clinical status or for their routine bloods tests to be conducted.] 
(Participant 6, 47 year old male). 
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4.5.2 Food shortages 
ART medication needing to be accompanied by food intake may hinder adherence 
Clients were advised at the clinic to take their ART medication after eating. Food shortages that 
occurred as a result of temporary unemployment, proved one of the barriers to clients’ adherence to 
ART, and hence leading to becoming LTFU from ART care. As one participant shared: 
‘The factory I was working for closed down and I did not have a job for a while, so 
sometimes I do not have food  to eat in the house and so couldn’t take my ARVs .I decided to 
stop collecting them because I sometimes don’t have food to take with the medication’ 
(Participant 7, 41 year old female ). 
A clinic key informant also indicated that this was a problem affecting ART adherence:  
‘A patient told me she had no food and was not going to waste her time collecting ARVs 
because she wasn’t going to take them anyway’ (KI, pharmacist). 
 
4.5.3 Stigma as a result of inadvertent disclosure 
Fear of rejection and emotional abuse 
The SACTWU ART clinic only services those members who are HIV positive, therefore everyone 
who is seen at the SACTWU clinic leads to inevitable disclosure of their HIV status to work 
colleagues who attend the same HIV clinic. HIV related stigma resulting from inadvertent disclosure 
of their HIV status was reported by both the participants and the key informants as one of barriers 
causing loss to follow up from ART. Some participants feared coming to the SACTWU ARV clinic 
because they feared they would experience HIV-related stigma as a result of being known by other 
fellow workers and employers to be attending the SACTWU clinic. 
‘I didn’t want people to know I go to the SACTWU ARV clinic because people always talks 
bad about people who are HIV positive that’s why I stopped going to collect’ (Participant 12, 
25 year old female). 
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One participant said she stopped going to the SACTWU ART clinic because she began to see many 
of her work colleagues going to the same clinic she attended. She feared that these work colleagues 
would then share with others at work that they had seen her attending the same ART clinic as they 
did. Even if her work colleagues did not have a problem with being known to be living with HIV, 
she still did not feel comfortable with them disclosing her status to other fellow workers. 
‘I stopped coming to the SACTWU clinic to collect my medication because there are a lot of 
people from work that I saw who go there too. I mean I know that they go there too because 
they are on ARVs, it’s just that…..the thing is I do not like it when they talk at work and 
telling everyone I also go with them to the clinic’ (Participant 8, 31 year old female). 
One key informant mentioned that she had advised clients to seek medical services at another health 
institution if they wanted to avoid an inadvertent disclosure instead of resorting to stop coming to the 
SACTWU clinic. 
‘I have always advised patients to consider being transferred out to their local clinic if they 
do not want to be seen by the people they work with, then they will not have to worry about 
being stigmatised at work by their fellow colleagues’ (KI, pharmacist).  
 
4.5.4 Discrimination 
Isolation and gossiping about PLWHIV 
One participant expressed that she had seen that there was discrimination towards individuals who 
were known to be living with HIV by other fellow employees at her workplace. This made her 
unwilling for her HIV status to be known, as she feared she would receive similar discriminatory 
treatment as with others known to be living with HIV at her workplace. 
‘I sometimes don’t like the people at work to know that I attend the SACTWU clinic because 
they will start talking about me at work and excluding me during lunch hours or in anything 
that they do so that’s why I decided to just pretend to be like them and stopped coming for my 
treatment cos in any case I’m not sick’ (Participant 7, 41 year old female). 
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4.5.5 Living conditions 
Overcrowding and lack of privacy hinder adherence 
Many people leave rural areas and seek employment in the urban areas. They rent accommodation 
near work, which they share with colleagues, friends and/or family. When people had not disclosed 
their HIV status to the people with whom they were living, it became difficult to adhere and to 
remain on their ART treatment. This could lead to them becoming LTFU. Participants reported: 
‘There are four of us sharing a room and no one knows my HIV status so it becomes difficult 
for me to keep my pill containers so eventually I decided to stop going to collect them’ 
(Participant 8, 31 year old female). 
‘I stopped going to the clinic because I have no privacy where I stay so even if I wanted to 
carry on its difficult’ (Participant 5, 59 year old male). 
A key informant commented: 
‘Because of poverty people live in crowded household and so a person who does not want to 
disclose their status would rather give up on coming to collect. It’s so sad because if 
communities would see HIV like any other illness we would not have so many people 
dropping out from treatment’ (KI, lay counsellor). 
 
 4.5.6 Work related pressures 
Being unable to take time off work acts as a barrier to adherence 
Patients who participated in the study expressed fears that if they often took too much or too frequent 
time off at work, this could result in them losing their employment. They were concerned that if they 
were constantly absent from work on a regular basis to attend clinic appointments and to refill their 
ART prescriptions this could place strain on the employer and employee relationship and jeopardise 
their employment situation. As a result, some decided to stop attending the clinic for their treatment 
and rather focus on retaining their job. Some of the participants reported that: 
‘My supervisor always shouts at me when I have to attend the clinic, say work needs to be 
done and he would say I must stay at home if I am sick. I got tired of my supervisor shouting 
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at me all the time I had to go to the clinic so I just decided to quit the clinic’ (Participant 7, 41 
year old female). 
‘I had to choose between my job and the clinic’ (Participant 3, 39 year old male). 
‘We were too busy at work, so I could not come to the clinic’ (Participant 11, 42 year old 
female). 
‘I had just started at a new job and I could not ask every time I needed to go to the            
clinic’ (Participant 12, 25 year old female). 
Clinic staff interviewed reported that they believed more needed to be done to educate employers, 
because this would decrease the numbers of patients LTFU because of work pressures: 
‘We need to go out to the factories and give more educational talks to the workers and more 
especially to the employers as well because their lack of knowledge and putting work first 
causes clients to be lost to follow up’ (KI, lay counsellor). 
	
	
4.6 HEALTH SYSTEM FACTORS 
Health systems factors relate to the way health services are organised and provided. This includes the 
accessibility of the facility, the overall environment of the facility, patient-provider relationships and 
support services offered at the facility.  
Health service factors that were reported as barriers for clients and that could lead to them becoming 
lost to follow up included long waiting times while seeking a clinic consultation, over-crowding, the 
isolation of ART clinic from other health services, and poor health worker-patient relationship. These 
were factors that were reported as influencing patients in not to coming to the clinic, and thus 
becoming lost to follow up. 
 
4.6.1 Poor healthcare provision 
Long waiting times at the clinic can contribute to lost to follow up 
Participants complained about long waiting times waiting to be attended to by healthcare providers at 
the SACTWU clinic. This became problematic as they were only allowed a limited time within a day 
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by their employers to go and seek medical care at the SACTWU ART clinic. Thereafter, they were 
paid per the number of hours worked or not paid at all if they did not make it to work on time if the 
limited time given to them to seek healthcare had been surpassed. Missing a whole day or a few 
hours of work had a negative impact on the workers financially, who would then rather stop 
attending the clinic. Participants expressed that: 
‘I never make it to work on time, at the pharmacy they make us wait nje (just) for long. The 
pharmacist is very slow and she knows we need to get to work. This ended up affecting me at 
work and[i] got paid less every time I have to go to the clinic. I wish they could deliver the 
tablets at our factory otherwise I would not have stopped going’ (Participant 3, 38 year old 
male). 
‘The nurses come late in the mornings and they go make their tea first while we wait I could 
not do it every month to go back there’ (Participant 8, 31 year old female). 
One of the key informants who had worked at the SACTWU clinic for a lengthy period explained 
that the SACTWU ART programme had expanded over the years, initiating a much larger number of 
clients onto ART. Some of the patients were unaware of the increase in patient numbers on ART. 
Having to wait much longer than previously to be attended to caused frustrations among patients and 
an increase in the number of ART patients who did not feel they could wait for such a long period to 
receive care. This was likely to have contributed to them becoming LTFU. 
‘When we started the ART roll out programme we had very few patients and they were all 
seen in the morning and they all used to make it to work on time. Patients forget that the 
programme has grown and is still growing, having a lot of patients than before so patients 
cannot compare the days when the clinic was starting and now, of course the waiting time 
will increase! Not everyone will get to work on time unfortunately and this has caused 
patients to drop out of care and become LTFU’(KI, pharmacist). 
 
4.6.2 Heath worker attitudes 
Negative attitudes and lack of support from healthcare workers 
Some clients complained of being disrespected when spoken to by the healthcare workers (HCW). 
These negative attitudes were seen as factors that discouraged patients from returning to the 
SACTWU clinic for their treatments. 
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‘Sometimes I forget my clinic card at home, but go to the clinic ngoba (because} I know my 
file number but the lady who gives us the files shouted at me in front of all the other patients 
ethi yena akasebenzi kanje (telling me this is not how the clinic operates) and sometimes 
would make me wait and gives those who have their clinic cards first, then mina (me).The 
attitude from the receptionist is always bad. I just left and never returned and that’s what I 
told them when they came looking for me’ (Participant 7, 41year old female). 
Many of the participants mentioned that the negative attitude they received at the SACTWU clinic 
from the HCW contributed a lot to causing delays in being attended to by the HCW at the clinic. 
They felt that the HCW did not take into consideration that patients were given limited time off work 
to attend the clinic. 
‘I sometimes go to the clinic during my lunchtime and ask for a pass out because the clinic is 
close to my work. The nurse would shout at me and say this is also their lunchtime. Why do I 
choose to come to the clinic at this time, as they all leave for lunch leaving us sitting on 
benches until their lunch hour is over’. I cannot come in the mornings because I would never 
make if for work and if I come during my lunch breaks the attitude and the treatment is even 
worse so I just didn’t bother coming back to collect the ARVs’ (Participant 1, 34 year old 
female). 
‘It was so much better when the old workers were still working at the clinic they knew we 
were rushing to work. These young nurses do not want to work. It really became difficult to 
return there’ (Participant 9, 55 year old female). 
One key informant concurred that some of the poor HCW attitudes towards patients could have 
contributed to the SACTWU clinic patients becoming LTFU. She stated: 
‘Nurses attitude contributes a lot to clients being lost to follow up, I have seen the way they 
treat patients and shout at them especially for coming just before they knock off work’ (KI, 
Social worker). 
 
4.6.3 Frequent clinic appointments 
Monthly ART clinic appointment seen as an inconvenience by patients 
Clinic appointments are scheduled monthly for patients to visit the clinic for a medication refill and 
health review by a clinician. Participants reported that these monthly visits to the SACTWU clinic 
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required them to take too much time off work over the course of a year. The frequency of clinic visits 
needed was inconvenient and deterred them from keeping all their appointments. 
‘Why can’t they give us pills for 3 months like I heard they do at government clinic? Here we 
have to come every month. I left for the clinic that my cousin gets his treatment so I don’t 
have to miss work so many times’ (Participant 12, 25 year old female). 
 
4.6.4 Isolation of the ARV clinic 
Isolation of the ARV clinic from other health services hindered adherence 
Having stand-alone clinics for those who are HIV positive was seen to be a barrier to clients’ clinic 
attendance and as contributing to becoming lost to follow up. The SACTWU ARV clinic was 
separated from the PHC clinic due to the growing number of patients having been initiated on to the 
ART program. This was to avoid too extensive overcrowding. Key informants concurred that this 
made a lot of the patients to become lost to follow up. They commented: 
‘With the clinics separated the clinic has lost a lot of patients on the ARV clinic side because 
the workers didn’t like the other workers knowing that they attend the ART clinic’ (KI 
professional nurse). 
Participants also admitted that they stopped coming to the SACTWU ART clinic because they did 
not understand why the two clinics had to be separated. 
‘Especially on a Friday when we finish early at work, I do not like to come to the clinic cos 
(because) a lot of people go on a Friday and the people not on ARVs will see me going to the 
ART clinic’ (Participant 2, 38 year old female). 
 	
4.7 CONCLUSION 
This chapter has presented the main findings of the study. The findings show that a range of 
individual related, socio-economic and health system factors contribute to patients becoming lost to 
follow up from ART care at the SACTWU clinic. Socio-economic factors and health systems factors 
were most commonly mentioned as barriers to remaining in ART care. These included 
unemployment, food shortages, frequent clinic visits and stand-alone clinics for ART care. 
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The following chapter discusses the findings of the study, relating them to the comparative literature 
in this area. 
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CHAPTER FIVE – DISCUSSION OF THE FINDINGS 
 
5.1 INTRODUCTION 
This chapter discusses the main study findings presented in the preceding chapter as factors 
contributing to LTFU among SACTWU Union Members on ART care. I will discuss these in 
conjunction with comparative literature in this area of study. 
 
The findings in this study revealed that the factors contributing to LTFU could be categorised into: 
individual (patient)-related factors, socio-economic factors and health system related factors. This is 
in line with the study findings of Bauleth (2013), Mathebula (2014) and Mwale (2016) and others, in 
which they also showed that the main contributing factors to ART patients’ poor adherence leading 
to LTFU fell into these categories. 
 
5.2 INDIVIDUAL FACTORS   
Patient-related factors influenced attitudes and behaviour towards consistent ART adherence and 
attending ART care. Themes that emerged related to patient-related factors that contributed to LTFU 
included: non-disclosure of HIV-positive status, not experiencing ill health, poor treatment literacy, 
alcohol abuse, travelling schedules and delays and alternatives to ART being available in the form of 
herbal medication. 
 
5.3.1 Disclosure 
The findings of the study revealed that the lack of disclosure of a person’s HIV status hindered 
adherence and was a noteworthy contributor to LTFU of the SACTWU union members from the 
ART clinic. HCW expressed the view that self-disclosure of a patient’s HIV-positive status to close 
family or friends could assist those on ART in adherence and keeping ART clinic appointments. 
They stated that having someone to remind them when it was time to take their medication daily 
could help. It could also assist by a person to whom they had disclosed their status being willing to 
attend the clinic on their behalf to collect medication if they were unable to make their clinic 
appointments. HCW reported always encouraging their clients who were initiated on ART to seek 
out close friends and family to whom they felt comfortable disclosing their status, and from whom 
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they could seek support. Bauleth (2013), who conducted a study in Oshakati Hospital in Namibia 
looking at factors associated with poor adherence amongst patients receiving antiretroviral therapy, 
reported that lack of disclosure of HIV status acted as a barrier to ART clinic attendance. Findings 
from Bauleth’s (2013) showed that, sometimes, when HCW were zealous in encouraging HV-
positive clients to disclose their status to relatives, the clients were reluctant to do so as they feared 
the reaction ad treatment they were likely to receive from relatives upon disclosure. This prompted 
them to rather stop attending the clinic for treatment than disclose their HIV status to relatives. A 
further contributory factor to LTFU from ART care to emerge from this study was that more 
participants feared that attending the ART clinic would lead to their HIV status becoming common 
knowledge amongst their colleagues and family. Bauleth’s (2013) study had similar findings. 
 
5.2.1 Not yet experiencing physical illness can affect perception of the need to be on ART  
The latest national ART treatment guidelines adopt a ‘test and treat’ strategy, which stipulates that all 
individuals that test positive for HIV must be initiated on ART immediately, regardless of their 
clinical staging or CD4 count (DOH, 2014). This guideline has increased the number of people being 
initiated on ART who have not yet experienced any physical illness from HIV. In this study, this 
emerged as a factor contributing to poor adherence and LTFU among patients who are on ART. The 
study found that participants who had not as yet experienced ill health were less motivated in taking 
their ART and tended to have poorer adherence and were more easily LTFU. In Bauleth’s (2013) 
qualitative study, a participant also mentioned that she stopped taking her ARVs because she was 
feeling better and thought it was not necessary for her to continue taking ART treatment. 
 
5.2.3 Poor treatment literacy 
Poor treatment literacy related to the taking of ART medication emerged in the study as a 
contributing factor to LTFU. For example, there were instances reported in which patients asked 
when they would be discharged from ART as they were feeling better. This indicated that some 
patients lacked the knowledge that it was essential that ART be seen as a lifelong treatment. 
Bauleth’s (2013) qualitative study found similarly that some participants stopped taking their ARTs 
because they felt better and thought it was unnecessary to continue with treatment. In both studies, 
participants clearly didn’t fully understand that the ART is lifelong treatment even when an 
individual is not experiencing physical illness. Patients who decided to stop taking their ART 
showed insufficient knowledge of the dangers and consequences of defaulting on ART treatment; 
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that includes greater individual vulnerability to a recurrence of HIV related illnesses and problems 
related to individuals and population resistance to particular ART medication due to interrupted 
treatment.  
 
5.2.4 Impact of alcohol use 
The study findings showed excessive alcohol intake having a negative effect on ART adherence, 
contributing to them becoming LTFU. This is in keeping with Mwale’s (2016) findings from a 
qualitative study conducted in Zambia that examined factors affecting retention in care of patients on 
ART in the Kadwe District in Zambia. Mwale’s (2016) study also found that excessive consumption 
of alcohol (in the form of beer drinking) caused patients to forget to take their ART medication, 
ultimately leading them to stop taking their medication altogether. Cramn et al. (2010) also found 
that consuming alcohol when on treatment had negative consequences for treatment adherence, with 
patients forgetting when to take their ARV treatment. 
 
5.2.5 Travelling 
All the participants in this research study were working class, with some of their jobs requiring them 
to travel extensively, which negatively affected their ART adherence. Mugisha, et al. (2007) 
conducted a study in Northern Uganda examining the reasons for LTFU among the ART clients, and 
they found that 7% of the participants were LTFU due to travelling and migration. In Mugisha et 
al.’s study (2007), some of the participants had permanently emigrated from the country for 
economic reasons. Mugisha et al. (2007) cite a study participant in a focus group discussion who 
reported that many patients found business opportunities in Southern Sudan and did not ever return.  
In our study, participants who were company drivers, whose job was to travel making deliveries and 
collections, frequently found that their travel was extended making it difficult to keep scheduled 
clinic appointments. This negatively impacted on their treatment adherence and visits to the clinic.  
Zulu’s (2009) qualitative study conducted at Murchison Hospital in KwaZulu Natal province in 
South Africa investigating factors associated with default of scheduled drug pick-ups and clinic visits 
by patients on ART, found that truck drivers were some of the patients most vulnerable to missing 
their ART treatment and one of the main groups of people affected by work schedule leading to 
LTFU. This shows that patients who were in job categories that involved extensive travel tended to 
become more likely to become LTFU from ART care. Other participants in our study reported travel 
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for social or family reasons, for example when someone was unwell back at home, and extended 
visits away from the usual residence, lead to them staying longer or moving permanently to another 
area. In Zulu’s (2009) study, some patients reported moving from the usual place of residence to an 
area where they didn’t usually attend ART care, because they preferred to die closer to home, placed 
them at greater risk of becoming LTFU from ART care. 
 
5.2.6 Alternatives to ART 
The impact of herbal medication on ART use and adherence 
The study established that even though the participants came to test for their HIV status and were 
enrolled on the ART program, a substantial number reported having tried using herbal to cure 
themselves of HIV medication. This is mostly influenced by seeing community members or 
colleagues advertise and encourage the use of herbal medication as a cure for HIV. A study 
conducted at Thembalethu Clinic Helen Joseph Hospital in Johannesburg that investigated LTFU of 
patients on ART also found that a decision to try the use of traditional medicine was one of the major 
reasons why some of the clients became LTFU (Maskew et al., 2007). In this research study, one 
participant reported having stopped taking ART due to being unable to collect their ART treatment 
and as a result adopted what they saw as a more practically feasible behaviour. This involved them 
opting for the use of traditional medicine, which their colleagues reported as having helped them in 
slowing down HIV progression, or as offering HIV cure, rather than missing treatment altogether. 
Peltzer et al.’s (2011b) study results concurred that use of herbal medication was associated with 
decreased ART adherence, leading to patients becoming LTFU from ART care. Antiretroviral 
therapy not providing a cure for HIV encouraged patients to seek other alternatives to ART such 
herbal remedies. This was in the hopes that these might provide a cure for their condition. 
 
5.3 SOCIO ECONOMIC FACTORS 
Socio economic factors have a great influence on the health of communities. Themes that related to 
socio economic factors that emerged from this study included cost and logistics, food shortages, 
stigma, discrimination, living conditions and work related pressures. 
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5.3.1 Cost and logistics 
Unemployment, even if this was temporary, contributed considerably to LTFU amongst the study 
participants. The SACTWU ART clinics are situated near members’ workplaces for the members’ 
convenience, in terms of transport and time costs. However, if members became unemployed, they 
were faced with cost and logistical problems in travel from their communities to one of the 
SACTWU ART clinics for consultations. Participants emphasised the financial difficulties incurred 
when they were either permanently or temporarily unemployed. Some clothing and textile industry 
factories employ a strategy of temporarily closing their factories during their ‘off-peak’ seasons, 
leaving their employees unemployed and without an income during the closure period. When 
unemployed, some workers moved back to their homes such as farms in rural areas. Study 
participants reported experiencing problems with cost of travel to get to the SACTWU ART clinics 
during times of unemployment, since the clinics were located closer to their previous workplaces 
than to their homes. The need to pay travel costs, particularly in the context of non-receipt of income, 
played a leading role in clients with HIV becoming LTFU. The Miller et al. (2010) cohort study 
showed similar findings, namely that financial difficulties experienced by clients meant that they did 
not have sufficient money for the transport costs to reach their usual health facility. This contributed 
to them becoming LTFU from treatment. Gelmanova et al.’s (2007) research findings also found 
unemployment to be associated with low socio-economic status that had negative impact on 
treatment adherence. Two of the KI in the current study commented on this subject by saying that 
patients who were unemployed were most commonly among those who would find it difficult to 
keep their clinic appointments and adhere to their treatment. They attributed this to the travelling 
costs involved in reaching the SACTWU clinic for care. 
	
5.3.2 Food shortages 
Food shortages also were reported to be a contributing factor for study participants becoming LTFU. 
Zvavamwe et al. (2008) mentions that successful completion of treatment in a patient is closely 
associated with the availability of food. Some participants reported that when they attended the clinic 
to obtain a re-issue of their monthly supply of medications HCW, in providing them with instructions 
on how to take the medication, stressed that they should take their medication after food. Hence, 
some study participants reported making a decision to stop collecting their treatment if they didn’t 
have sufficient food to take with their medication. This had an influence in their becoming LTFU 
from treatment. Mathebula’s (2014) study conducted in Thekganang ARV clinic in Pretoria, South 
Africa that similarly examined reasons for LTFU from HIV care, had similar findings that food 
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shortages (having nothing to eat) hampered patients’ ART adherence and clinic attendance. Murray 
et al. (2009) and Weiser et al. (2003) in their findings, also concurred with this study’s findings that 
food shortages impacted negatively on patients’ determination to take and adhere to ART. Even 
though their appetite improved after initiating ART treatment, continued adherence was hampered by 
having no food, and thus contributed to them becoming LTFU from care. 
 
5.3.3 Stigma 
HIV associated stigma is associated with poor knowledge, fear of the disease and death and unsafe 
sexual behaviour (Theron, 2005). The study participants all reported that they felt that living with 
HIV was for the most part stigmatised. They feared disclosing their HIV status because of fears of 
rejection. This included fears that they would be abandoned by an intimate partner if they disclosed 
their HIV-positive status, as well as fear of stigmatisation or being subject to gossiping at work if 
they were seen attending the HIV/ART clinic. Hardon, et al.’s (2006) cohort studies conducted in 
three different countries (Botswana, Uganda and Tanzania) had similar findings. In Hardon et al. 
(2006), participants reported feeling that they had to hide the fact that they were taking ART 
medication, due to fears that this would create gossiping about them. Charurat (2010) also found that, 
although the number of treatment facilities had been increased and made more accessible to 
communities, patients still continued to avoid accessing care at facilities within own communities 
because of their fear of stigma. Wasti et al. (2012) also found that PLWH avoided seeking treatment 
at their nearest clinic because of fears of stigmatisation. The WHO (2006) reported that HIV 
stigmatisation remained a major problem hindering HIV treatment and care. 
 
5.3.4 Discrimination 
In this current study, discrimination contributed to patients becoming LTFU as patients feared  that it 
being known that they were living with HIV would create a situation of isolation and rejection from 
partners, relatives or colleagues. Due to poor knowledge of HIV and AIDS, communities often have 
misconceptions about this condition. When a person tests positive for HIV they therefore find it 
difficult to disclose their status because of what they have heard or seen people around them say 
about people living with HIV. In the current study, most participants feared for their status to become 
known, or taking their medication in front of their families, friends or work colleagues, due to fears 
that they would experience discrimination as a result. In Bauleth’s (2013) study also found that 
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participants feared experiencing isolation by friends, who would keep a distance from them if they 
discovered their HIV positive status.  
 
5.3.5 Living conditions 
5.3.5.1 Overcrowding and lack of privacy 
Some study participants reported sharing rooms with colleagues or relatives as they were not 
originally from Durban, but residing in the city for work purposes. They shared rooms to save on 
rent money so they would have money to send back home every month. The participants concurred 
that this overcrowding (sharing of rooms) contributed to their non-adherence and eventually 
contributed to their becoming LTFU. These findings are compatible with those of Mathebula (2014). 
A participant in his study reported that as he lived in a hostel sharing a room with his other 
colleagues, he feared taking his ART medication in front of them and therefore became non-
adherent. Wasti et al. (2012) also mention that most patients reported being embarrassed about their 
HIV status and being therefore concerned about the lack of sufficient privacy to take their ART 
alone. Having to try and take medication in front of other people led to their skipping their ART 
doses. This experience of lack of lack of privacy seems to contribute to patients not going back to 
clinics to collect their ART treatment and hence becoming LTFU from care. Overcrowding and lack 
of privacy cross-cut with fears of stigma and discrimination and act as deterrents to some patients 
remaining on ART. 
 
5.3.6 Work related pressures 
Being on lifelong ART, like any other chronic illness, requires dedicated time for clinic visits, which 
means taking time away from work. The SACTWU workers work daily and for long hours and 
sometimes on weekends without rest. Many SACTWU employees are contract workers. Their 
employment can therefore be particularly jeopardised if they take too much time off work. Some 
employers view taking substantial amounts of time off work for healthcare visits as making an 
employee unfit for their job. This could result in termination of a worker’s employment. Those 
participants who were contract workers were paid per number of hours worked. Therefore, the more 
hours they spent at a health facility, the less they got paid. This created difficulties, as each time 
workers took time off to work to go to the clinic they were faced with being paid less at work due to 
the number of hours they lost working while at the clinic. These financial difficulties contributed to 
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them becoming LTFU. Maskew et al. (2007), who conducted a similar study to this one elsewhere in 
South Africa, also highlighted financial difficulties as a leading cause of LTFU among the ART 
patients. Similarly in Zulu’s (2009) study some participants reported that they felt they had to choose 
between their jobs and attending the clinic. In both the Green (2004) and Bauleth (2013) studies, 
participants reported stopping taking their ART treatment in order to retain their employment. 
 
5.4 HEALTH SYSTEM ORGANISATIONAL FACTORS 
Heath system organisational factors examine how the health services are managed and delivered, the 
heath facility environment, health care provider-patient relationships and medication (Mukumbang et 
al., 2017). During the interviews with the participants, the four subthemes related to health system 
organisational factors contributing to patients from the SACTWU clinic being LTFU were: 
inadequate service quality, which included long waiting times; frequency of clinic visits; clinic 
structure and operational issues such as stand-alone clinics separated from other services that could 
then be easily identified as catering to HIV care and treatment; and in the case of some HCW, poor 
health worker attitudes to patients. 
 
5.4.1 Long waiting times 
The long waiting times for consultations with healthcare provider, and at the pharmacy to collect 
medication, were cause of much frustration for study participants. These affected their willingness to 
keep clinic appointments and had a negative impact on their earnings as it meant fewer hours worked 
in a day. This contributes to LTFU from care. Zulu’s (2009) study concurs that a loss of working 
time comprises a pressing and immediate concern for patients, as long waiting times at healthcare 
facilities cause them financial harm. In Bauleth’s (2013) study, similar complaints were reported, 
namely that patients faced long waiting times at clinics. These findings were also common in the 
studies conducted by Miller et al. (2010) and Mathebula (2014), who also reported that clients 
complained about the long waiting times at healthcare facilities.   
   
5.4.2 Frequent clinic appointments 
Clinic appointments are determined by a number of factors, which include availability of drug supply 
at the clinic, adherence issues that a patient might be having and whether a patient is clinically stable 
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or not. The SACTWU clinics collect their ART drug supply from King Edward Hospital, which 
sometimes does not supply a sufficient amount of the drugs required for the number of patients the 
SACTWU clinics cater for. If the patients have other co-morbidities like hypertension or diabetes 
which are insufficiently controlled and need attention from a clinician, then the patients will be seen 
more often than if there are no co-morbidities. Most of the patients did not seem to receive sufficient 
information on, or did not understand, the processes causing delays. This added to their sense of 
frustration and acted as a deterrent to them attending the clinic. Complaints of only receiving one 
month’s supply of ART treatment from the SACTWU clinic instead of three months’ supply, as was 
the practice at most government public sector clinics, acted as an additional hindering factor in 
remaining on treatment. This complaint was linked to problems related to the financial costs of 
having to attend the clinic on a monthly basis. In Mwale’s (2016) study conducted in Kabwe District, 
Zambia, participants had similar concerns about receiving only one month’s instead of three months’ 
drug supply. 
 
5.4.3 Stand-alone clinics 
In government hospitals and clinics, for operational reasons, the ART clinics or sections are usually 
separate from the general outpatient departments, and in some hospitals the ART department has its 
own pharmacy. These ART clinics are often assigned their own special name that is different from 
that of the hospital or other clinic. Initially, the SACTWU health facilities were not separated into 
two separate general primary care and ART clinics. However, with an increase in the number of 
SACTWU members enrolled in its ART program, the facilities were separated, as more space was 
needed and having two clinics situated opposite each other in one road. One is solely for ART 
treatment and care, and the other is a general primary health care clinic. This emerged as a source of 
unhappiness among participants and contributed to some of the ART patients who did not want to be 
seen using the ART clinic, to stop attending the clinic for fear of their HIV status being known. 
 
5.4.4 Health worker attitudes 
Poor health worker attitudes towards ART patients can lead to a poor patient-health worker 
relationship, which can have a negative effect on adherence, eventually and potentially leading to 
LTFU from care. In the current study, many participants expressed concern about the negative 
attitudes they sometimes experienced from some of the health care workers. This took the form of 
being reprimanded or shouted at. Some participants complained that some HCW were not 
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sympathetic if they complained about losing pay because of long waiting times at the clinics and 
were unhappy if they attended the clinic over lunch time when HCW wanted to take their lunch 
break. One participant singled out staff working in reception as being particularly uncaring in their 
attitudes towards the patients. Similar sentiments were expressed in Zulu’s (2009) study conducted in 
Murchison Hospital in KwaZulu Natal province in South Africa, looking at reasons for default 
follow up of ART, where reception staff at the facility clinic from which they collected their 
treatment were perceived as being short tempered. In Miller et al.’s (2010) study conducted in South 
Africa, similar findings emerged, with a participant who had lost his clinic card reporting that he was 
reluctant to go back to the clinic as staff at the reception routinely turned patients away if they were 
not in possession of their clinic cards. In Bauleth’s (2013) over-critical attitudes from some HCW 
were also seen as deterring patients from attending healthcare facilities. 
 
5.5. STUDY LIMITATIONS 
This qualitative study was not aimed at being generalizable to all LTFU patients from HIV care. The 
study only included those clients who were LTFU but returned to care, and did not include those who 
were permanently LTFU in care.  
The study only focused on patients attending a clinic for the trade union members, which kept the 
study limited geographically to the urban area of Durban in KwaZulu Natal, and therefore the 
findings may not be reflective of the situation in other urban centres or in rural areas.  
Nevertheless, the findings provided insights that are useful to the SACTWU clinic in its efforts to 
better retain its union members on ART into care, and can provide valuable insights on which to base 
research in other similar settings. 
 
5.6 CONCLUSION 
The study findings discussed were interlinked, and mostly influenced by the socio-economic status 
of the workers and their difficulty in disclosure of their HIV status. Despite the trade union’s efforts 
to ensure easy accessible health services to their members, these factors are still an issue. Reasons for 
LTFU among the SACTWU union members on ART appeared to resonate with those in a number of 
other studies in different countries. 
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The next chapter outlines the overall conclusions of the study, and recommendations are discussed 
with respect to addressing some of the factors causing LTFU of ART patients at the SACTWU ART 
clinic. 
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CHAPTER 6 - CONCLUSION AND RECOMMENDATION 
 
6.1 INTRODUCTION 
In summary, this study’s aim was to explore factors associated with loss to follow up of clients on 
ART treatment among the South African Clothing and Textile Union members living with HIV and 
attending the SACTWU Worker Health Clinic in Durban, South Africa.  
 
6.2 SUMMARY OF CONCLUSIONS 
This exploratory study demonstrated that the reasons that the SACTWU ART patients are LTFU are 
interlinked and complex. In implementing this research, participants who had been LTFU but 
subsequently returned for treatment were selected and interviewed using in-depth interviews. Health-
care workers also provided their opinions on this topic through focus group sessions. The purpose of 
the study was to provide insights on the causes for patients becoming LTFU so as to assist the 
SACTWU clinic management, health care workers, the trade union SACTWU and the employers to 
develop strategies to decrease the incidence of LTFU at the SACTWU ART clinic. Adherence of 
individuals and retention to ART care of PLWH will not only improve the ART programme but 
prolong the life for PLWH.  
The study demonstrated that the reasons that the SACTWU ART patients are LTFU are interlinked 
and complex. The main contributing factors to LTFU identified were: individual- related factors, 
socio economic-factors and health-system related factors. Key individual factors included non-
disclosure of HIV status, not yet experiencing physical illness as a result of living with HIV, poor 
antiretroviral treatment literacy, the impact of excessive alcohol use, travelling away from the clinics 
clients routinely attend for ART services, and use of alternatives to ART.  
Economic factors primarily related to the costs to individuals of reaching the ART clinics, 
particularly when the clients were unemployed, and food shortage. Social factors deterring ART 
adherence included: stigma, discrimination, overcrowded living conditions that created lack of 
privacy, and work-related pressures. 
Dominant health-system factors included poor health service provision, difficulties created by the 
need for monthly clinic appointments, stand-alone clinics leading to potential inadvertent disclosure 
of their HIV status and negative attitudes by some health workers. 
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6.3 RECOMMENDATIONS 
As loss to follow up remains a problem amongst the SACTCWU clinic ART patients despite the 
SACTWU union’s initiative of offering health services specifically for union members close to their 
place of employment, key areas identified as contributing to LTFU could assist in addressing some 
of the factors promoting loss to follow up. Below, I outline a set of key recommendations: 
 
6.3.1 RECOMMENDATIONS REGARDING INDIVIDUAL FACTORS 
In order to address the problem of non-disclosure of a person’s HIV status as a leading barrier to 
patients ending up being LTFU, ways to encourage and deal with the possible need for the disclosure 
of HIV status should be pre-emptively discussed with patients before the lay counsellor performs an 
HIV test so that should the patient test positive, potential plans for disclosure have been developed.  
Should a person test HIV positive, these potential plans for the importance of disclosure and practical 
methods for a patient to disclose their HIV-positive status to key individuals who they trust should be 
further discussed. Patients should be aware of the benefits that disclosure of their status to selected 
individuals has, that is, of having someone who can provide them with emotional support. Disclosure 
will also assist those on ART to receive assistance, if and when necessary, with collection of the 
ART when difficulties arise preventing the worker from leaving work to collect medication. It can 
also assist in provision of adherence support. This can also be an opportunity to improve knowledge 
if gaps in knowledge are identified. Patients should be encouraged to be accompanied by the person 
to whom they have chosen to disclose their HIV status when they attend their second scheduled 
appointment at the health facility. This will assist the person who accompanies the patient to become 
a support person to the patient and allow the lay counsellor and social worker to assess the level of 
knowledge the supporter has on HIV and in treatment. This can also be an opportunity to improve 
both the patient’s and the support person’s knowledge of HIV and ART, if gaps in the knowledge are 
identified. As the national HIV/AIDS guidelines being implemented in KwaZulu Natal involve ‘test 
and treat’, many individuals are now being initiated on ART before they begin to experience signs of 
AIDS-related illness. This stresses the need for counsellors to provide more in depth and convincing 
information to patients about the importance of continuing on ART despite feeling healthy, as this 
will ensure that they do not experience future possibilities of opportunistic infections and ill health as 
a result of HIV weakening their immune system.  
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Knowledge gaps identified with regards to treatment literacy among the SACTWU ART patients 
need to be attended to by the HCW at the SACTWU clinics. Further opportunities need to be created 
for HCW to continue to strengthen ART treatment literacy with patients at every follow up 
appointment. Improved ART literacy will create improved patient knowledge on ART drugs and 
HIV as a whole so as to encourage greater commitment and motivation to continue taking ART so as 
to remain healthy. 
Patients should also receive counselling on the risks of alcohol intake while on ART and encouraged 
to avoid excessive consumption. They should also be counselled not to stop taking ART if they have 
been drinking but to rather continue even if they have missed some medication doses. Support 
groups could be established for those who are at serious risk of being unable to stop consuming 
alcohol.  
Frequent travelling has also contributed to patients becoming LTFU. They should be adequately 
informed of the different options available to receive their medication, when travelling or if 
travelling is extended unexpectedly. Those who travel frequently can be equipped with referral 
letters certifying that the patient is on ART treatment and which type of ART they are on, so they are 
able to seek for refills of their treatment at any nearby facility while travelling. Patients without 
referral letters can be informed that they should always have their clinic carrier card in their 
possession so they can produce the card at the nearest facility as evidence to the next facility that the 
patient is on ART, so they can be assisted with a refill of their treatment. These patients should also 
be advised not to wait till their medication is finished before seeking help.  
Herbal medication use as an alternative to ART was also identified as a contributing factor to 
SACTW patients being LTFU. The use of herbal medication and its potential risks in causing some 
negative effects on organs in the body should be discussed during literacy education. It should also 
be emphasized that herbal medication cannot cure the HIV virus.  
 
6.3.2 RECOMMENDATIONS REGARDING SOCIO ECONOMIC FACTORS 
Costs and logistical problems contributed to the SACTWU ART clients being LTFU when they 
became unemployed or were temporarily unemployed. Unemployment sometimes occurred when 
factories closed down either permanently or temporarily - when factories closed down during the 
slack periods leaving the patients without an income and therefore with no means to pay for transport 
costs to attend at the clinic situated near their work area. A strategy should be developed to assist 
those who are unemployed in applying for their unemployment insurance fund (UIF) benefits, to 
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assist the patients financially while they are unemployed and seeking new employment. Those who 
are unemployed should be issued with transfer letters to their local clinics, where cost of transport 
can be reduced or eliminated. 
Food shortages have contributed to LTFU among the SACTWU ART patients. Patients on ART 
therapy are usually instructed to take their ART medication after a meal. This can cause frustration 
when there is not enough food in the household for patients to eat before taking medication. This has 
been a cause of some patients interrupting their ART treatment and sometimes stopping collecting 
their medication from the clinic altogether. Strategies that could be implemented include for the 
SACTWU clinic to organise and offer food parcels, a food  allowance or food vouchers for those 
members who are ART patients, as long as they are adherent to his or her medication. This could 
also encourage other SACTWU union members who have never been tested for HIV to get tested 
and know their status because they will realise that the SACTWU ART clinic takes good care of their 
members on ART treatment. 
Stigma and discrimination emerged as a cause of LTFU among some SACTWU ART patients. 
Stigma and discrimination towards PLWH result from lack of knowledge among community 
members about HIV/AIDS. This leads to community misconceptions and myths about HIV and 
AIDS. A strategy towards reducing stigma and discrimination could be to develop community-based 
campaigns that educate the community about HIV/AIDS to ensure that they are knowledgeable about 
HIV and can therefore treat those living with HIV like any others living with a chronic illness. 
Communities can be enlightened about different ways of contracting HIV, which could lessen the 
perception that this virus is contracted through promiscuous behaviour. Communities could be 
educated that HIV positive people are ‘still normal’ individuals and that the HIV virus is not 
transmitted in an airborne manner and cannot be contracted like influenza or by being in the same 
room as an HIV positive individual. Health care workers could also visit different clothing and 
textile factories to give educational talks on HIV/AIDS. 
Overcrowding and lack of privacy in the homes also emerged as one of the contributing factors for 
SACTWU ART patients being LTFU. Those who had not disclosed their HIV-positive status were 
most affected by this, as it was difficult to take their medication religiously, as they feared that those 
they lived with might notice they are taking medication on a regular basis and may start asking 
uncomfortable questions. Patients who are initiated on ART should be encouraged to disclose their 
HIV status, especially to those they live with, so that it becomes easier for them to take their 
treatment, without having to hide that they are doing so. Offers could also be made to bring in those 
individuals they live with on their visits to the clinic or for the clinic health care workers to conduct 
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home visits so as to educate those with whom clients live on the HIV and AIDS illnesses. With a 
more knowledgeable and accepting community, people on ART would not feel ashamed when 
having to take their ART and so would be less likely to resort to becoming LTFU. 
Work related pressures were also among the barriers contributing to patients becoming LTFU, with 
some of the participants choosing to go to work over attending the health facility to collect 
medication, because they felt that they could not leave work. Work related pressures led to their 
feeling unable to take time off work, even if this was only for a few hours because of work or 
because of employee shortage at their workplace. They felt pressurised in these circumstances by the 
employer not to take time off to attend at the clinic. The SACTWU ART clinic managers should 
engage with the employers and educate them and provide them with accurate information on 
HIV/AIDS and what it means when a client is started on ART. This could influence employers in 
having an improved understanding of why workers living with HIV need to take some time off work 
to attend clinic appointments. The employers could in addition employ a qualified health care worker 
at their company who could assist with collecting pre-packed medication at the ART SACTWU 
clinic and dispensing these to their employees living with HIV, thus eliminating the need for them to 
take time off to attend at the clinic, unless this was necessary in order to have to have their bloods 
taken. This strategy could increase adherence and decrease clients being LTFU. This would also 
mean that patients agreeing to this arrangement could be made more comfortable in indirectly 
disclosing their HIV status to their employer. This strategy could save the SACTWU ART patients 
from taking time off work only to collect their monthly medication, and could also make employers 
satisfied as fewer employees will be absent or late for work due to medication collections. Those 
patients who would prefer not to have their medication dropped off at their work place could be 
linked to the Central Chronic Medication Dispensing and Distribution (CMDD) programme in their 
area, where they are able to collect medication after hours or during weekends. Offering these kinds 
of convenient services could encourage patients who were not adherent to become adherent to their 
medication by providing easier ways of receiving their medication, either at work or at a CMMD 
site. 
 
6.3.3 RECOMMENDATIONS REGARDING HEALTH SYSTEMS FACTORS 
Long waiting times at the SACTWU ART clinic emerged as a contributing factor to clients 
becoming LTFU. A number of individuals reported having to spend much of their time out and stop 
all their other activities to wait at the clinic to collect their ART medication. Some patients reported 
that having limited time available to allocate to collect their medication caused them distress. 
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Participants highlighted that the long waiting times at the clinic also caused them to lose payment for 
the hours they spent at the clinic rather than at work as this decreased their salary payments. 
Strategies that could be put in place include a fast tracking system at the SACTWU clinic for those 
patients who are clinically stable and show signs of good adherence. These patients could be fast 
tracked by allowing them to proceed straight to the pharmacy where their medication would be pre-
packed and ready for pick up. These patients could also be given a larger medicine supply to cover 
more months of treatment so as to minimise the time they had to allocate in their busy schedule to 
visit a health facility. These patients could additionally be given the opportunity to be able to send a 
friend or a relative to collect their ART on their behalf, except on occasions where their annual blood 
tests have to be conducted or when they had to attend the clinic themselves in order to receive their 
blood test  results. A further strategy that the SACTWU clinic could adopt is to have ART 
medication pre-packed for those patients who are stable on their medication and have it delivered to 
the work place or a collection point of their choice. SACTWU could also implement a CMDD 
programme and link their stable patients to community programmes, where they could collect their 
ART. All these strategies could have the potential to increase adherence and retention of the 
SACTWU members on ART.  
Patients will realise that if a person is adherent to his/her medication, the system of collection of 
ART medication can be made more convenient, without compromising their employment situation. 
These strategies would also assist decrease the number of patients needing to consult a HCW at the 
clinic and ultimately decreasing the waiting times for all patients.  
Having to attend frequent monthly clinic visits to collect ART treatment emerged as a contributory 
factor to patients becoming LTFU. Reasons why patients are recalled to visit the clinic frequently 
include poor adherence to ART, having other chronic medical conditions, or shortages of drug 
supplies in the facility to provide clients with more than one month’s medication supply. Patients 
who need to see the health care worker monthly should be provided with a proper explanation for 
why they need to return monthly. If adherence is the key reason for attending monthly, if provided 
with an explanation, these clients may be motivated to ensure improved adherence to avoid having to 
make frequent to see a HCW. The SACTWU clinic appears to be experiencing a problem of 
receiving insufficient supplies of ART from King Edward hospital to enable all patients to receive 
more than one month’s supply of medication. The SACTWU clinic managers should attempt to 
obtain their own demander code from the department of health (DOH) so that the clinic can receive 
its own drug supply directly from the suppliers. A demander code is having the SACTWU health 
facilities registered independently so they are able to order and receive their drug supplies from the 
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manufacturers. This will enable stable ART patients to receive more than one month’s supply of their 
ART drugs, and therefore decrease the clinic visits necessary. 
Having a stand-alone SACTWU ART clinic was intended to create space for the growing number of 
patients being initiated on ART, and also to provide specialised care to the ART patients. However, 
this emerged as contributing to patients becoming LTFU as they feared being seen at the clinic by 
other fellow employees. A strategy should be employed to offer ART services at both SACTWU 
clinics (the stand-alone ART clinic and the general PHC clinic) so that a patient who did not wish to 
be seen as living with HIV has the option of obtaining their ART without having to collect this from 
the ART clinic. This will cause less frustration and fear of being discriminated against and exposed 
as a person living with HIV. 
Healthcare worker attitudes towards patients on ART were found to contribute to some SACTWU 
clinic patients becoming LTFU. When healthcare workers are employed, they should not only be 
knowledgeable about the HIV disease and treatment, but should also be trained in good quality of 
care and adopting positive and sympathetic attitudes towards all patients including those LWHIV. 
They need to be better informed about PLWH’s emotions and sense of vulnerability, so that they are 
in a position to provide support and empathy to patients. If health care workers display a caring 
attitude and understanding to patients coming to collect their ART, it will make it easier for the 
patients to come to visit the clinic and they will feel freer to ask questions or talk about any issues 
they might have.  
 
6.4. CONCLUSION 
In conclusion, HIV/AIDS still remains a problem in the health sector. Managing HIV/AIDS requires 
a public health approach, which entails holistic management around the illness. While the SACTWU 
union assists with offering ART health service to its members living with HIV, holistic management 
will assist in addressing the underlying issues that cause LTFU amongst patients on ART care. 
Addressing underlying issues of patient-related factors, socio-economic factors and health system 
factors will decrease patients becoming LTFU, which in turn reduces public health effectiveness of 
provision of ART care. This will assist in reaching the ’90-90-90’ goal of ending the HIV epidemic. 
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APPENDIX 1A: CONSENT FORM 
UNIVERSITY OF THE WESTERN CAPE 
                            Private Bag X 17, Bellville  
                                 7535, South Africa 
                              Te l :  +27 21-959 9382  
                              Fax:  27 21-959 2872  
                                   E-mail: snziqubu@gmail.com 
 
CONSENT	FORM	
Title	of	Research	Project:	An	exploration	of	loss	to	follow	up	from	HIV	care	among	the	South	
African	Clothing	and	Textile	Workers	Union.		
The	study	has	been	described	 to	me	 in	 language	 that	 I	understand.	My	questions	about	 the	study	
have	been	answered.	I	understand	what	my	participation	will	involve	and	I	agree	to	participate	of	my	
own	choice	and	free	will.		I	understand	that	my	identity	will	not	be	disclosed	to	anyone.	I	understand	
that	I	may	withdraw	from	the	study	at	any	time	without	giving	a	reason	and	without	fear	of	negative	
consequences	or	loss	of	benefits.				
	
Participant’s name……………………….. 
Participant’s signature……………………………….            
Date……………………… 
Researcher  
I have read this document to the participant, in Isizulu or given this to them to read.  I have 
tried to answer his questions to the best of my knowledge.  
 
Date:                                    Signature of Researcher:_____________________  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
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APPENDIX 1B: CONSENT FORM 
 
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
																																																				CONSENT	FORM	
Isihloko	socwaningo:	An	exploration	of	 loss	to	follow	up	from	HIV	care	among	the	South	African	
Clothing	and	Textile	Workers	Union.		 	
Lolu	 cwaningo	 liye	 lachazwa	 kimi	 ngolimi	 engilaziyo	 nengiliqondayo.	 Imibuzo	 yami	 mayelana	
nesifundo	 iye	 yaphenduleka.	 Ngiyaqonda	 ukuthi	 ukuhlanganyela	 kami	 nokuzibandakanya	 futhi	
ngiyavuma	 ukubamba	 iqhaza	 ngokuthandayo	 kwami	 nangokuzikhethela.	 Ngiyaqonda	 ukuthi	
imininingwane	yami	ngeke	yaziswe	omunye	umuntu.	Ngiyaqonda	ukuthi	ngingahoxa	kulolucwaningo	
noma	 inini	 ngaphandle	 kokunikeza	 isizathu	 futhi	 ngaphandle	 kokwesaba	 imiphumela	 engemihle	
noma	ukulahleka	izinzuzo.	
	
Igama	lobambe	iqhaza……………………	
Isignesha	yobambe	iqhaza……………………	
Usuku…………………..	
Umcwaningi: 
Ngibafundele ngolimi lwesiZulu, ngabanika iphepha ukuze bazifundele mayelana 
nocwaningo laba abazozibandakanya nocwaningo. Ngizamile ukuphendula yonke imibuzo 
yabo ngocwaningo.  
Usuku:                                    Sayina:_____________________  
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
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APPENDIX 2A: INFORMATION SHEET-CLIENT  
		 
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
 
INFORMATION	SHEET-CLIENT		
	
Project	Title:	An	exploration	of	 loss	to	follow	from	HIV	care	among	the	South	African	Clothing	and	
Textile	workers	Union.	
	
What	is	this	study	about?		
This	 is	 a	 research	 project	 being	 conducted	 by	 Dr	 S.N	 Ziqubu	 as	 part	 of	 Masters	 in	 Public	 Health	
course	 at	 the	University	of	 the	Western	Cape.	 	We	are	 inviting	 you	 to	participate	 in	 this	 research	
project	because	you	stopped	coming	 to	HIV	care	 for	your	ART	 for	a	while	at	 the	SACTWU	Worker	
Health	Program	Clinic.	The	purpose	of	this	research	project	is	to	explore	the	difficulties	you	faced	in	
continuing	coming	 for	HIV	care	and	how	these	were	overcome.	Exploring	 these	 reasons	will	 assist	
the		SACTWU	Worker	Health	clinic	in	coming	up	with	strategies	to	provide	better	services	to	clients	
to	 assist	 people	 such	 as	 yourself	 in	 continuing	 to	 come	 to	 the	 clinic.	We	 would	 like	 to	 ask	 your	
permission	to	interview	you.	
What	will	I	be	asked	to	do	if	I	agree	to	participate?	
You	will	be	asked	to	participate	in	an	interview	if	you	agree	to	be	part	of	the	study.	The	interview	will	
be	 conducted	 with	 your	 permission	 and	 I	 will	 be	 interviewing	 you.	 	 I	 will	 be	 asking	 you	 some	
questions	and	discuss	with	you	the	issues	that	you	think	are	contributing	to	clients	having	difficulties	
in	returning	for	to	HIV	care	or	make	it	easier	for	them	to	come	here.	This	session	will	take	an	about	
hour.	I	will	be	talking	to	you	alone.	Our	conversation	will	be	tape	recorded	with	your	permission	so	I	
can	be	able	to	listen	to	our	interview	again	to	make	sure	I	can	remember	all	that	you	have	said.	
 
http://etd.uwc.ac.za/
	68	
	
Would	my	participation	in	this	study	be	kept	confidential?	
The	researchers	promise	to	protect	your	identity	and	what	you	tell	them.	To	ensure	your	anonymity	
that	no-	one	knows	what	you	have	said	I	will	give	you	a	number	codes	and	not	use	your	real	names	
in	talking	about	what	you	have	said	to	anyone.	I	will	be	the	only	person	who	will	keep	the	informed	
consent	 forms	 and	 consent	 for	 interview	 sheet	 which	 you	 have	 signed.	 These	 forms	will	 be	 kept	
separate	from	the	information	you	will	provide	me	during	the	interview	so	that	what	you	say	will	not	
be	linked	to	your	signature.	To	ensure	confidentiality	after	the	interview,	the	information	which	you	
have	given	me	will	be	kept	in	locked	cupboard	and	what	you	have	told	me	will	only	be	identified	by	
your	unique	number	code.		
If	we	write	a	report	or	article	about	this	research	project,	your	identity	will	be	protected.	I	will	use	a	
number	or	name	that	cannot	be	linked	to	you.	
What	are	the	risks	of	this	research?	
There	may	be	some	risks	from	participating	in	this	research	study.	For	this	study	you	may	feel	some	
emotional	discomfort.	Living	with	HIV	and	talking	about	 it	may	bring	about	feelings	of	emotions	of	
sadness.	
Whenever	people	talk	about	themselves	or	others	this	carries	some	amount	of	risks	or	discomfort.	
We	 will	 make	 these	 risks	 or	 discomfort	 smaller	 by	 quickly	 helping	 you	 if	 you	 experience	 any	
discomfort,	 psychological	 or	 otherwise	 during	 the	 interview.	 If	 you	 feel	 you	 would	 like	 this,	 an	
appropriate	 referral	 to	 the	 right	 type	 of	 care	 worker	 will	 be	 made	 if	 you	 want	 any	 help	 or	
intervention.	
What	are	the	benefits	of	this	research?		
This	research	is	not	designed	to	help	you	personally,	but	the	results	may	help	me	learn	more	about	
reasons	why	clients	get	lost	to	ART	care	at	SACTWU	Worker	Health	Clinic.	We	hope	that	in	the	future	
other	people	like	you	might	benefit	from	this	study	through	improved	understanding	of	what	made	
people	 like	 yourself	 to	 get	 lost	 from	 HIV	 care.	 This	 can	 help	 assist	 the	 clinic	 in	 coming	 up	 with	
strategies	to	improve	services	in	such	a	way	to	help	clients	stay	in	care.	
Do	I	have	to	be	in	this	research	and	may	I	stop	participating	at	any	time?			
Your	 taking	part	 in	 the	 research	 is	 voluntary.	 	 You	may	also	 choose	not	 to	 take	part	at	all.	 	 If	 you	
decide	to	participate	 in	this	research,	you	may	stop	participating	at	any	time.	 	 If	you	decide	not	to	
participate	in	this	study	or	if	you	stop	participating	at	any	time,	you	will	not	be	penalized	or	lose	any	
benefits	to	which	you	otherwise	qualify.	
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What	if	I	have	questions?	
This	research	is	being	conducted	by	Dr	Sibusisiwe	Ziqubu	at	the	University	of	the	Western	Cape.		If	
you	have	any	questions	about	the	research	study	itself,	please	contact:	
Dr	S.N	Ziqubu	
Tel:	0313055581	
Cell:0764402134	
Email:snziqubu@gmail.com	
Should	you	have	any	questions	regarding	this	study	and	your	rights	as	a	research	participant	or	if	you	
wish	to	report	any	problems	you	have	experienced	related	to	the	study,	please	contact:		
		
Supervisor: Prof Diane Cooper 
School of Public Health 
Faculty of Community and Health Sciences:  
University of the Western Cape 
Email: dcooper@uwc.ac.za 
 
Head of Department: Prof Helen Schneider 
School of Public Health 
Faculty of Community and Health Sciences:  
University of the Western Cape 
Email: Helen.Schneider@uwc.ac.za 
Private Bag X17; Bellville 7535         
 
Dean of the Faculty of Community and Health Sciences:  
Prof José Frantz  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za  
 
This research has been approved by the University of the Western Cape’s Research Ethics 
Committee. (REFERENCE NUMBER: BM/17/1/10) 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office  
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APPENDIX 2B: ULWAZI SHEET - CLIENT 
	
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
 
ULWAZI SHEET - CLIENT 
 
Isihloko Project : An Exploration of  Loss to Follow Up from HIV care among the South 
African Clothing and Textile workers Union. 
 
Simayelana nani isifundo ? 
Lena wocwaningo olwenziwa ngo- Dr S.N Ziqubu njengengxenye ye Masters eqeleni Public 
Health e-University of the Western Cape . Siyakumema ukuba ubambe iqhaza kule project 
ucwaningo ngoba wake walahleka ekuzinakekelweni HIV nokuza kumtholampilo wakho 
wakwa SACTWU Worker Program emitholampilo . Inhloso yale phrojekthi ucwaningo 
ukuhlola ngenxa yezizathu zokuthi kungani ubungasezi ukuqhubeka uzela ukunakekelwa 
HIV . Ukuhlola lezi zizathu ezizosisiza emtholampilo yethu SACTWU Worker Health 
ekhuphuka nge amasu ukuze sihlinzeke izinhlelo ezingcono kubo amaklayenti ukusiza abantu 
abanjalo njengoba uzithanda wena ekuqhubekeni ukuza emtholampilo ekubeni . Sithanda 
ukucela imvume yakho ukuze interview kuwe 
 
Yini edingeka kumina uma ngivuma ukuba kucwaningo? 
Uma uvuma ukuba babe yingxenye yokutadisha, uma kutholakale imvume yenu 
ngizakuphiwa ithuba lokuxoxa nawe. Mina ngibe ngibuza imibuzo futhi nixoxe 
izimpikiswano sandla kumakhasimende nobunzima e kokubuyela ngoba HIV ukunakekela 
.Lokhu kuzothatha ihora. Ngizobe ngikhuluma nawe wedwa . Ingxoxo yethu uyoba iqoshiwe 
ngemvume yakho ukuze ngikwazi ukuyisiza uzokwazi ukulalela interview yethu ukuze 
uqiniseke Nginilobele futhi zikhumbule nakho konke lokho wena uthé. 
 
Ingabe ukuhlanganyela kwami kulo kulolu cwaningo iyogcinwa iyimfihlo? 
Umcwaningi uzokwenza isiqiniseko sokuthi akekho owaziyo ukuthi ungubani futhi lokho 
okushilo. Ukuze kuqinisekiswe igama lakho; ngiyakuninika okufaneleyo amakhodi hhayi 
ukusebenzisa amagama akho yangempela ukukhuluma ngalokho wathi ubani. I kuyoba 
kuphela umuntu kuyogcina wazisa amafomu emvume nolwazi ishidi ngazo ngemvume. Lawa 
mafomu izobe bazigcina behlukile ulwazi uyobe uhlinzeke kimi. Ngemva interview 
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ukuqinisekisa ubumfihlo, ulwazi onginike kimi azohlala amakhabethe lockable futhi 
kuyokwenziwa kuphela ekhonjwe yi ikhodi yakho ehlukile okuzokwenziwa kuphela ungazise 
kuphela. 
 
Uma sibhala umbiko noma isihloko ngalokhu wocwaningo, mina ngeke niphathe igama lakho 
noma yini engase zembule ukuthi ungubani. 
 
Ziyini izingozi zalesi ucwaningo? 
Kungase kube ezinye izingozi ngokomzwelo ukubamba iqhaza kulolu cwaningo ucwaningo. 
Being HIV positive nokukhuluma esingase silethe ngayo ngemizwa noma ukuphoxeka noma 
nokudabuka. 
Zonke ekuxhumaneni womuntu nokukhuluma self noma abanye baphatha nenani izingozi. 
Sizokwenza nokho wukuzama lezi zingozi njengoba encane ngangokunokwenzeka futhi 
usabela ngokushesha ukukusiza uma uhlangabezana ukungakhululeki, ezingokwengqondo 
noma yanoma iluphi uhlobo ngesikhathi inqubo kwakho iqhaza kulolu cwaningo. Lapho 
kunesidingo khona, uma ungathanda lokhu, i yokudluliselwa ezifanele, zizokwenziwa a 
professional efanelekayo olunye usizo noma ukungenelela. 
 
Ziyini izinzuzo zalesi ucwaningo? 
Lolu cwaningo ngeke eklanyelwe ukusiza wena uqobo, kodwa imiphumela ingase isize 
umphenyi ufunde kabanzi mayelana nezizathu eziye zenza ukuba amaklayenti ulahleke ukuba 
ukunakekelwa HIV ngesikhathi SACTWU Worker Umtholampilo wezempilo. Ngithemba 
ukuthi, esikhathini esizayo abanye abantu bangase bazuze kulolu cwaningo ngokusebenzisa 
ukuqonda kangcono ukuthi yini eyenza abantu abafana nawe bakwazi ukubuyela 
ukunakekelwa HIV ozokusiza kimi uzongisiza e ekhuphuka nge amasu ukuthuthukisa 
amasevisi e ezifana ngendlela ukuze asize uhlale ekunakekelweni. 
 
Kumele yini ngibe kulolucwaningo, ngingayeka yini uma ngithanda? 
ingxenye Your ukungenisa cwaningo yokuzithandela. Ungase futhi ukhethe ukuba angathathi 
ingxenye nhlobo. Uma unquma ukuba iqhaza kulolucwaningo, ungase uyeke iqhaza nganoma 
yisiphi isikhathi. Uma unquma hhayi iqhaza kulolu cwaningo noma uma uyeka iqhaza 
nganoma yisiphi isikhathi, ngeke bajeziswe noma ukulahlekelwa yinoma yiliphi izinzuzo 
kuso ngenye ufanelekele 
 
Kuthiwani uma nginemibuzo? 
Lolu cwaningo lwenziwa ngu Dr Sibusisiwe Ziqubu e-University of the Western Cape. Uma 
unanoma yimiphi imibuzo mayelana ucwaningo ngokwayo, sicela uthintane: 
Dr	S.N	Ziqubu	
Tel:	0313055581	
Cell:0764402134	
Email:snziqubu@gmail.com	
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Uma kufanele unemibuzo mayelana lolu cwaningo kanye namalungelo akho njengoba 
umhlanganyeli ucwaningo noma uma ufisa ukubika izinkinga uke wabhekana ahlobene 
cwaningo, sicela uthintane: 
  
Supervisor: Prof Diane Cooper 
School of Public Health 
Faculty of Community and Health Sciences:  
University of the Western Cape 
Email: dcooper@uwc.ac.za 
 
Head of Department: Prof Helen Schneider 
School of Public Health 
Faculty of Community and Health Sciences:  
University of the Western Cape 
Email: Helen.Schneider@uwc.ac.za 
Private Bag X17; Bellville 7535         
 
Dean of the Faculty of Community and Health Sciences:  
Prof José Frantz  
University of the Western Cape 
Private Bag X17 
Bellville 7535  
chs-deansoffice@uwc.ac.za  
 
This research has been approved by the University of the Western Cape’s Research Ethics 
Committee. (REFERENCE NUMBER: BM/17/1/10) 
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office 
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APPENDIX 3A: FOCUS GROUP CONFIDENTIALITY 
BINDING FORM 
 
 
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
	
FOCUS	GROUP	CONFIDENTIALITY	BINDING	FORM	
Title	of	Research	Project:	An	Exploration	of	Loss	to	Follow	Up	from	HIV	Care	Among	the	South	
African	Clothing	and	Textile	Workers	Union.	
	
The	study	has	been	described	 to	me	 in	 language	 that	 I	understand.	My	questions	about	 the	study	
have	been	answered.	I	understand	what	my	participation	will	involve	and	I	agree	to	participate	of	my	
own	 choice	 and	 free	 will.	 	 I	 understand	 that	 my	 identity	 will	 not	 be	 disclosed	 to	 anyone	 by	 the	
researchers.	 I	understand	that	 I	may	withdraw	from	the	study	at	any	time	without	giving	a	reason	
and	without	 fear	of	negative	 consequences	or	 loss	of	benefits.	 I	 understand	 that	 confidentiality	 is	
dependent	on	participants’	in	the	Focus	Group	maintaining	confidentiality.		
I	hereby	agree	to	uphold	the	confidentiality	of	the	discussions	 in	the	focus	group	by	not	disclosing	
the	 identity	of	other	participants	or	 any	aspects	of	 their	 contributions	 to	members	outside	of	 the	
group.	
	
Participant’s name……………………………………….. 
Participant’s signature…………………………………..             
Date……………………… 
Researcher  
I	have	read	this	document	to	the	participant,	in	Isizulu	or	given	this	to	them	to	read.		I	have	tried	to	
answer	his	questions	to	the	best	of	my	knowledge.		
Date:																												 								Signature	of	Researcher:_____________________		
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
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Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
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APPENDIX 3B: Isivumelwano 
 
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
 
Isivumelwano	sokuthula	ngokukhulunyiwe	kwiGroup	yocwaningo	
Isihloko	Research	Project:	An	isihlonzi	Ukulahlekelwa	Yokulandela	Phakamisa	HIV	Care	Among	the	
Clothing	South	African	and	Textile	Workers	Union.	
	
Lolu	 cwaningo	 iye	 yachazwa	 kimi	 ngolimi	 Ngiyaqonda.	 imibuzo	 yami	 mayelana	 nesifundo	 Kuye	
waphendula.	 Ngiyaqonda	 ukuthi	 ukuhlanganyela	 kwami	 kuzobandakanya	 futhi	 ngiyavumelana	
iqhaza	 engiwuthandayo	 siqu	 yokuzikhethela.	 Ngiyaqonda	 ukuthi	 ungubani	 lami	 ngeke	 wachazela	
kunoma	ubani	kwenziwa	yinoma	abacwaningi.	Ngiyaqonda	ukuthi	enyuke	asuke	cwaningo	nganoma	
isiphi	 isikhathi	ngaphandle	kokunikeza	isizathu	futhi	ngaphandle	kokwesaba	imiphumela	engemihle	
noma	 ukulahleka	 izinzuzo.	 Ngiyaqonda	 ukuthi	 imfihlo	 yawo	 ixhomeke	 kwababambiqhaza	 in	 the	
Focus	Group	egcine	ubumfihlo.	
	
I	uyavuma	ukugcina	into	exoxiwe	kwiFocus	group	imfihlo	nokuthi	ikhulunywe	ngubani.	
Igama	obambe	iqhaza	.............................................	..	
isignesha	obambe	iqhaza	.......................................	..	
Usuku	...........................	
Umcwaningi:	
Ngibafundele	 ngolimi	 lwesiZulu,	 ngabanika	 iphepha	 ukuze	 bazifundele	mayelana	 nocwaningo	 laba	
abazozibandakanya	nocwaningo.	Ngizamile	ukuphendula	yonke	imibuzo	yabo	ngocwaningo.		
Usuku:																												 								Sayina:_____________________	
BIOMEDICAL RESEARCH ETHICS ADMINISTRATION  
Research Office 
New Arts Building, 
C-Block, Top Floor, Room 28 
University of the Western Cape 
Private Bag X17 
Bellville 7535  
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APPENDIX 4A: INFORMATION SHEET –SERVICE 
PROVIDER 
 
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
 
INFORMATION	SHEET	–SERVICE	PROVIDER	
Project	Title:	An	Exploration	of	Loss	to	Follow	up	from	HIV	Care	among	the	South	African	Clothing	
and	Textile	Workers	Union.	
What	is	this	study	about?		
This	is	a	research	project	being	conducted	by	Dr	S.N	Ziqubu	as	part	of	her	Masters	in	public	Health	
course	 at	 the	University	of	 the	Western	Cape.	 	We	are	 inviting	 you	 to	participate	 in	 this	 research	
project	because	you	work	at	 the	SACTWU	worker	health	clinic	and	have	engaged	with	clients	 that	
are	lost	to	follow	up	from	HIV	care.	The	purpose	of	this	research	project	is	to	explore	why	you	think	
clients	get	lost	to	follow	up	and	to	assist	come	up	with	strategies	to	prevent	this	from	happening.	
	
What	will	I	be	asked	to	do	if	I	agree	to	participate?	
You	will	be	asked	to	 take	part	 in	a	group	 interview	with	other	service	providers	 from	your	clinic	 if	
you	agree	to	participate	in	the	study.	You	will	be	asked	questions	and	discuss	the	issues	contributing	
to	clients	being	lost	to	follow	up.	The	group	session	should	take	about	an	hour.	The	interview	will	be	
tape	recorded	with	your	permission	so	 I	can	be	able	to	 listen	to	 it	again	to	make	sure	 I	remember	
everything	and	have	captured	everything	that	the	group	has	said.	
	
Would	my	participation	in	this	study	be	kept	confidential?	
The	 researchers	undertake	 to	protect	 your	 identity	and	 the	nature	of	 your	 contribution.To	ensure	
your	 anonymity	 you	will	 all	 be	 given	 number	 codes	 and	 I	 will	 not	 use	 your	 real	 names	 in	 talking	
about	what	you	have	said	in	the	group.	I	will	be	the	only	person	who	will	keep	the	informed	consent	
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forms,	 information	 sheet	 and	 focus	 group	 confidentiality	 binding	 form.	 These	 forms	 will	 be	 kept	
separate	from	the	information	the	group	will	provide	me	with	during	the	discussion.	After	the	group	
interview	to	ensure	confidentiality,	the	information	which	you	have	given	together	with	the	rest	of	
the	 group	will	 be	 kept	 in	 a	 lockable	 cabinet	 and	will	 only	 be	 identified	 by	 your	 unique	 individual	
number	code.	
	
If	we	write	a	report	or	article	about	this	research	project,	I	will	not	mention	your	name	or	anything	
that	might	reveal	who	you	are.	
Since	this	interview	will	be	done	in	a	group	the	extent	to	which	your	identity	will	remain	confidential	
is	dependent	on	participants	in	the	group	maintaining	confidentiality.			
What	are	the	risks	of	this	research?	
There	may	be	minimal	risk	associated	with	participating	in	this	research	study	such	as	emotional	risk.	
You	may	experience	fear	or	fell	uncomfortable	talking	among	the	group	as	they	are	your	colleagues	
or	 because	 I	 am	 interviewing	 you	 and	 also	 at	 the	 same	 time	 I	 am	 your	manager	 at	 the	 clinic.	 All	
human	interactions	and	talking	about	self	or	others	carry	some	amount	of	risks.	We	will	nevertheless	
minimize	such	risks	and	act	promptly	to	assist	you	if	you	experience	any	discomfort,	psychological	or	
otherwise	during	 the	process	of	 your	participation	 in	 this	 study.	Where	necessary,	 an	appropriate	
referral	will	be	made	to	a	suitable	professional	for	further	assistance	or	intervention.			
What	are	the	benefits	of	this	research?	
This	research	is	not	designed	to	help	you	personally,	but	the	results	may	help	the	investigator	learn	
more	about	reasons	why	clients	get	lost	to	HIV	care	at	SACTWU	Worker	Health	Clinic.	I	hope	that,	in	
the	 future,	 other	 people	might	 benefit	 from	 this	 study	 through	 improved	 understanding	 of	 what	
makes	people	 in	 the	 clinic	 get	 lost	 to	 follow	up	 from	HIV	 care	which	may	assist	 in	 contributing	 to	
recommendation	for	strategies	to	prevent	this	from	happening.		
Do	I	have	to	be	in	this	research	and	may	I	stop	participating	at	any	time?			
Your	participation	in	this	research	is	completely	voluntary.		You	may	choose	not	to	take	part	at	all.		If	
you	decide	to	participate	in	this	research,	you	may	stop	participating	at	any	time.		If	you	decide	not	
to	participate	in	this	study	or	if	you	stop	participating	at	any	time,	you	will	not	be	penalized	or	lose	
any	benefits	to	which	you	otherwise	qualify	or	affect	your	work	negatively	in	any	way.	
What	if	I	have	questions?	
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This	research	is	being	conducted	by	Dr	Sibusisiwe	Ziqubu	at	the	University	of	the	Western	Cape.		If	
you	have	any	questions	about	the	research	study	itself,	please	contact:	
Dr	S.N	Ziqubu	
Tel:	031305581	
Cell:0764402134	
Email:	snziqubu@gmail.com	
	
Supervisor: Prof Diane Cooper 
School of Public Health 
Faculty of Community and Health Sciences:  
University of the Western Cape 
Email: dcooper@uwc.ac.za 
 
Head	of	Department:	Prof	Helen	Schneider	
School	of	Public	Health	
Faculty	of	Community	and	Health	Sciences:		
University	of	the	Western	Cape	
Email:	Helen.Schneider@uwc.ac.za	
Private	Bag	X17;	Bellville	7535									
	
Dean	of	the	Faculty	of	Community	and	Health	Sciences:		
Prof	José	Frantz		
University	of	the	Western	Cape	
Private	Bag	X17	
Bellville	7535		
chs-deansoffice@uwc.ac.za		
	
This	research	has	been	approved	by	the	University	of	the	Western	Cape’s	Research	Ethics	
Committee.	(REFERENCE	NUMBER:	BM/17/1/10)	
BIOMEDICAL	RESEARCH	ETHICS	ADMINISTRATION		
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APPENDIX 4B: ULWAZI SHEET (PROVIDER) 
 
UNIVERSITY OF THE WESTERN CAPE 
 
Private Bag X 17, Bellville 7535, South Africa 
Tel :  +27 21-959 382 Fax: 27 21-959 2872 
                                                     E-mail: snziqubu@gmail.com 
 
ULWAZI SHEET Zokusebenzela PROVIDER 
 
Isihloko Project: An exploration of loss to follow up from HIV Care among the South 
African Clothing and Textile Workers Union. 
 
Lumayelana nani ucwaningo? 
Lena wocwaningo olwenziwa ngo-Dr S.N Ziqubu njengengxenye ye Masters wakhe eqeleni 
Health yomphakathi e-University of the Western Cape. Thina ukumema ukuba iqhaza kule 
project ucwaningo ngoba ukusebenza SACTWU isisebenzi sezempilo emtholampilo futhi ne- 
amaklayenti kwabalahlwayo zokulandelela ekukhathazekeni HIV. Inhloso yale phrojekthi 
ucwaningo ukuhlola ukuthi kungani amaklayenti ulahleke ukulandela up nokusiza beveza 
amasu ukuvimbela lokhu kungenzeki. 
 
Ngizodingakalani kumina uma ngizibandakanya nocwaningo? 
Uma uvuma ukuba babe yingxenye yokutadisha, uma kutholakale imvume yakho uzobe 
ezibandakanyekayo interview yeqembu nomunye bezempilo emtholampilo wakho. Uzocelwa 
imibuzo futhi nixoxe izimpikiswano sandla kumakhasimende ukuduka ukuze silandele udaba 
lwakhe. The selicembu kumele uzithathele ihora. I interview kuyoba tape aqoshiwe 
ngemvume yakho ukuze ngikwazi ukuyisiza uzokwazi ukulalela futhi ukuze uqiniseke 
ngiyakhumbula konke futhi wanqoba konke leli qembu ngoLwesine. 
 
Ingabe ukuhlanganyela kwami kulo kulolu cwaningo iyogcinwa iyimfihlo? 
Ukuze kuqinisekiswe igama lakho niyakubhubha ngokunjalo nonke uzonikezwa amakhodi 
ezahlukene hhayi ukusebenzisa amagama akho yangempela ukukhuluma ngalokho kusho leli 
qembu. I kuyoba kuphela umuntu kuyogcina wazisa amafomu emvume, ulwazi ishidi bese 
sigxila iqembu ngaphandle kokugcinwa kuyimfihlo ngibopha ifomu. Lawa mafomu izobe 
bazigcina behlukile ulwazi qembu ngenzele. Ngemva interview iqembu ukuqinisekisa 
ubumfihlo, ulwazi onginike ndawonye neqembu uyogcinwa Ekhabetheni lockable futhi 
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kuyokwenziwa kuphela ekhonjwe yi ikhodi yakho ehlukile ngamunye okuzokwenziwa 
kuphela ungazise kuphela. 
 
Uma sibhala umbiko noma isihloko ngalokhu wocwaningo, mina ngeke niphathe igama lakho 
noma yini engase zembule ukuthi ungubani. 
 
Njengoba le interview kuzokwenziwa iqembu ngezinga elingakanani ubuwena bakho ngeke 
yimfihlo luncike abahlanganyeli eqenjini egcine ubumfihlo. 
	
Ziyini izingozi zalesi ucwaningo? 
Kungase kube ingozi sakugcina ezihlobene ne iqhaza kulolu cwaningo ucwaningo ezifana 
ingozi ngokomzwelo. Ungezwa ukwesaba noma wawa ungakhululekile ukukhuluma phakathi 
kweqembu njengoba benjalo osebenza nabo noma ngoba ngiyahamba enkhulumoluhlolo 
lawe ngesikhathi esifanayo I am umphathi wakho emtholampilo. Zonke ekuxhumaneni 
womuntu nokukhuluma self noma abanye baphatha nenani izingozi. Sizokwenza nokho 
ezimboza ingxenye enkulu ezingozini ezinjalo futhi senze ngokushesha ukukusiza uma 
uhlangabezana ukungakhululeki, ngokwengqondo noma ngenye ngesikhathi senqubo kwakho 
iqhaza kulolu cwaningo. Lapho kunesidingo khona, i yokudluliselwa ezifanele zizokwenziwa 
a professional efanelekayo olunye usizo noma ukungenelela. 
 
Ziyini izinzuzo zalesi ucwaningo? 
Lolu cwaningo ngeke eklanyelwe ukusiza wena uqobo, kodwa imiphumela ingase isize 
umphenyi ufunde kabanzi mayelana nezizathu eziye zenza ukuba amaklayenti ulahleke ukuba 
ukunakekelwa HIV ngesikhathi SACTWU Worker Umtholampilo wezempilo. Ngithemba 
ukuthi, esikhathini esizayo, abanye abantu bangase bazuze kulolu cwaningo ngokusebenzisa 
ukuqonda kangcono ukuthi yini eyenza abantu emtholampilo ulahleke ukuze silandele udaba 
lwakhe ekunakekelweni HIV oluzosiza kimi enomthelela isincomo sokuba amasu 
ukuvimbela lokhu kungenzeki. 
 
Ingabe Kudingeka ngibe kulolucwaningo futhi kwangathi ngiyeke iqhaza nganoma isiphi 
isikhathi? 
Ukubamba kwakho iqhaza kulolucwaningo kuyinto yokuzithandela ngokuphelele. Ningase 
nikhethe ukungaxoxi ukuthatha ingxenye nhlobo. Uma unquma ukuba iqhaza 
kulolucwaningo, ungase uyeke iqhaza nganoma yisiphi isikhathi. Uma unquma hhayi iqhaza 
kulolu cwaningo noma uma uyeka iqhaza nganoma yisiphi isikhathi, ngeke bajeziswe noma 
ukulahlekelwa yinoma yiliphi izinzuzo kuso ngenye ufanelekele. 
 
Kuthiwani uma nginemibuzo? 
Lolu cwaningo lwenziwa ngu Dr Sibusisiwe Ziqubu e-University of the Western Cape. Uma 
unanoma yimiphi imibuzo mayelana ucwaningo ngokwayo, sicela uthintane: 
Dr S.N Ziqubu 
Tel: 031305581 
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Cell: 0764402134 
Email: snziqubu@gmail.com 
	
Uma unemibuzo mayelana kulolu cwaningo kanye namalungelo akho njengoba 
umhlanganyeli ucwaningo noma uma ufisa ukubika izinkinga uke wabhekana ahlobene 
cwaningo , sicela uthintane : 
 
Supervisor:	Prof	Diane	Cooper	
School	of	Public	Health	
Faculty	of	Community	and	Health	Sciences:		
University	of	the	Western	Cape	
Email:	dcooper@uwc.ac.za	
	
Head	of	Department:	Prof	Helen	Schneider	
School	of	Public	Health	
Faculty	of	Community	and	Health	Sciences:		
University	of	the	Western	Cape	
Email:	Helen.Schneider@uwc.ac.za	
Private	Bag	X17;	Bellville	7535									
	
Dean	of	the	Faculty	of	Community	and	Health	Sciences:		
Prof	José	Frantz		
University	of	the	Western	Cape	
Private	Bag	X17	
Bellville	7535		
chs-deansoffice@uwc.ac.za		
	
This	research	has	been	approved	by	the	University	of	the	Western	Cape’s	Research	Ethics	
Committee.	(REFERENCE	NUMBER:	BM/17/1/10)	
BIOMEDICAL	RESEARCH	ETHICS	ADMINISTRATION		
Research	Office	
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APPENDIX 5: (PATIENTS) 
 
Semi-structured interview guide 
 
Topic Area 1-Experiences on access to HIV services 
 
1.1 What is your impression about availability broadly of HIV health services in ? 
a) Can we speak about your experience of receiving services at the state hospitals 
and also at specialized clinics like this one or any other you assessed services 
(Probes for example: What did you think about the general environment and 
atmosphere at the facility? How did you feel about the skills of those who 
attended to you? How did you find the attitudes of the healthcare workers who 
attend/ed to you? Did/do they ask you what you felt were appropriate questions 
about yourself? Did/do you have a chance to and want to ask them questions? 
How was the amount of time you spent with them and the length of time you 
waited to see them?Did you have time to ask them the questions you wanted to? 
Did they ask you questions and explained things well or not? In comparison to 
other centres you have assessed ART services, was the experience different. If yes 
or no can you tell me more about this. 
1.2 Can you think back to when you first tested for HIV and share with me your personal 
experience of HIV testing:        
a) What was your motivation to test for HIV and why so? 
b) What motivated you at the time to access HIV care services? 
c) Can you share with me how the test result impacted you physically, 
psychologically and emotionally at the time? 
d)  Can you talk about whether you feel you have accepted your HIV status or 
not and share your journey of acceptance of your HIV status ?  
(PROBES:  
Who did you confide in about your HIV status, if anyone; what were their 
reactions; did you get   support or not, from who and what kind of support? 
What things helped you in accepting your status; what things hampered them; 
what made the biggest difference in acceptance?) 
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e) Do you think you having HIV has impacted on quality of services generally 
that you receive at this clinic? Why do you think it did or did not? 
 
Topic Area 2- Experiences of ART therapy and access to ART  
2.1 Can you share your experience with me about how you decided to start taking ART? 
What were the motivating or demotivating factors to begin treatment, your inspiration, what 
spurred you into action? Was there anyone who persuaded you it was the right time to begin? 
If so, who, what did they say and what made you feel persuaded? 
 
 2.2 Can you go through step by step with me, the process that explains how you access ART 
at the clinic for each visit? 
             
a) How do you come to a conclusion on the number of clinic visits you make in a 
year?  
            b) Describe the process you go through 
  2.3 Can you share your experiences negative or positive related to you accessing ART at 
this facility or anywhere else also? Compare your experiences at this clinic with the previous 
places you assessed ART, if any. 
 
Topic Area 3- Experiences on adherence to ART 
3.1 What ART medication/s did you start on? Which ones are you on now?  
3.2 What do you know or where about these medications and what were you told about them, 
for example , how they work in the body 
3.3 When you started ART what was your experience with the drugs/medications? How did 
they make you feel? 
3.4 How did you handle the side effects of the medications if any? 
3.5 What about the ART medication now, how do you feel on them? 
3.6 Can you tell me about the impact of the ART on your overall health? 
3.7 Can you share with me your journey in being able to take your ART medication all the 
time or not consistently or not since you started the medication? 
3.8 Tell me about the periods that you stopped taking the medication and events/ happenings 
in your life at the time that may have affected your stopping. 
3.9 How was is that you came back to the clinic and started taking ART again? What things 
made you to do this? How have you found it taking your ART medication again? Can you 
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talk about anything that is making it easier or still difficult in taking your ART 
medication all the time now? 
3.10 Can you talk about the major stressors in your life and how they affect adherence? 
Have you experienced any periods of depression or anxiety or not? What mechanisms 
have you put in place to cope with this? Did you get help? Or did this push you into any 
use of substances like alcohol or recreational drug use? 
3.11 What are the uplifting things in your life that may help your adherence? 
3.12 Can you speak about challenges and triumphs on your adherence journey so far?  
(PROBES: What helps you in taking your medication? What hinders you in taking your 
medication?) 
3.13 What is your experience with support systems/people/ family in this adherence journey? 
Do they know that you are living with HIV?  
3.14  Who are they, can you talk about their relationship with you and how this has helped 
you or not adhere to ART? Do they play a part in helping or hindering you to adhere? 
3.15 Can you explain how they got involved with supporting you in this journey? 
3.16 Can you talk about openness to your partner /s about you being a person living with 
HIV, and how you think this has affected how you adhere? 
3.17 What is the role of family (parents, siblings, other family) on your adherence? 
3.18 Can you speak about other friends – maybe some of them are in the same position as 
you, some not, - in this adherence journey and what role do they play in your ART 
adherence? 
 
 
Topic Area4-Societal and economic factors 
 
 4.1. Based on your experience, do you think that there is any relationship between societal 
perceptions of HIV and your adherence to ART? What have you experienced? In your 
experience, has the way people view this in society/community, the way media representation 
of adherence campaigns affected your practices on ART adherence? Can you talk about the 
role this has played or not? 
  4.2 What other remedies and treatments are you currently using or have used in the past 
together with your ART medication? What do you use these other remedies for? What is your 
motivation for this? (tradition/faith/ poverty?) 
  4.3  What is the importance or not of financial stability on your adherence to ART? 
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(Probe for shelter/ gainful employment/ access to food?) 
  4.4 Can you share with us your personal living conditions and how this impacts on your 
adherence? (Probe for shared living conditions (with parents/ partner/ friends) and how this 
affects adherence; Probe for mobility and fixed status. If he is moving around constantly, how 
does this affect adherence). 
	
WHEN FINISHED: 
 
Thank you for your time and open discussion on such sensitive issues. I really appreciate 
it. 
Is there any question(s) you will like to ask me or anything you will like to discuss with 
me?  
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APPENDIX 6: (SERVICE PROVIDERS) 
 
Semi-structured	interview	guide	
Topic Area 1-Experiences on access to HIV services 
 
1.1. What is your impression about availability broadly of HIV health services in 
Durban? 
a) Can we speak about your experience of giving services at the public sector 
facilities and also at specialized clinics like this one or any other you worked in 
previously? If this happens to be your first work experience with clients living 
with HIV, what do you think, from your contact with them, is their impression of 
services rendered here? How does it compare with public sector facilities? (Probe 
for example: What do they tell you about the general environment of this clinic? 
Do you think they are satisfied with your skill level? Have you gotten into a 
conversation about healthcare worker attitudes in this clinic in comparison to 
other state hospitals? If yes, what is their general perception about this?  
I. b) Do you think your clients are satisfied with the waiting times to see you? Why 
do you think so? Do you think you spend enough time with clients judging by 
their satisfaction levels after consultation?  Have your clients spoken about their 
overall experience here in comparison to other centres they have assessed 
services and describe what they say? And the reason they give for it being 
different? How do you feel about the waiting times yourself? 
1.2 In your experience, what motivates clients to access HIV testing services? 
a)  What issues do your clients face after a positive HIV test result?   Can you 
share with me how you think the test result impacts them physically, 
psychologically and emotionally? 
b)   Can you tell me about the difficulties that your clients face in their 
acceptance of their HIV status? What in your experience ameliorates the 
difficulties and improve their journeys of acceptance (PROBES:  
Who do they confide in about their HIV status, if anyone; what were their 
reactions; did they get   support or not, from whom do they get this support 
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and what kind of support? What things helped you in accepting your status; 
What things hampered them; what made the biggest difference in acceptance?) 
c) Tell me about your reaction when you first diagnosed clients with HIV and 
now in your present position here as a health care worker.  
 (PROBES: 
Describe the clients’ disposition in respect of their comfortability, feeling of 
safety and trust. Did you feel that it was a difficult process for the client? If 
you do, why so? Did you feel that you had enough knowledge, sensitization 
and competency to deal with the information on your clients’ HIV status? If 
yes, why do you come to this conclusion? If no, why do you come to this 
conclusion? Can you describe your reaction after you had told them about 
their status, if any? How in your opinion did you think your reaction made 
them feel?)How do you feel about ongoing training in ART : how do you feel 
about the management support you are given in doing your 
 
d) Do you think that your clients feared that being diagnosed with HIV would 
affect negatively or positively affect quality of services they would receive in the 
future? Why do you think they had this fear or not? What do you think – do you 
feel it has made any difference to you? 
 
Topic Area 2- Experiences of ART therapy and access to ART  
2.1 In your experience of seeing multiple clients, what do you think persuades clients 
to start taking ART? Can you describe the common motivating and demotivating 
factors to begin treatment? What are the common reasons given as inspiration to start 
treatment?  
2.2 Can you go through with me, step by step, the process that explains how your 
clients access ART at the clinic for each visit?  
a) How do you plan the number of clinic visits you designate to each client per 
year? What do you base this on?  
2.3 What negative or positive experiences relating to clients accessing ART at this 
clinic, have clients shared with you?  In your experience, how do they think this clinic 
measures in service delivery to them compared to previous places they say they have 
accessed ART services. 
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Topic Area 3- Experiences on adherence to ART 
3.1 When your clients start ART, what are the experiences they shared with you 
concerning the side effects of the drugs? 
3.2 How do you describe to them their expectations around side effects before they 
start the drugs and how do you affirm and comfort them after they have started the 
drugs and are experiences side effects? 
 3.3 Can you tell me how clients describe the impact of the ART on their overall 
health? How does this make you feel when you see a client adhering and doing well 
on ART? 
 3.4 Can you share with me what your clients cite as major reasons for staying and 
adhering to ART and also what makes them discontinue? How do they describe their 
overall journey of consistently adhering or not consistently adhering to ART?  
 3.5 To what extent do your clients ascribe discontinuing taking their medication to 
happenings and events in their lives at work or at home the time? 
 3.6 Can you tell me what your clients describe as major stressors in their lives and 
how these affect their adherence? Have you had clients complain about depression or 
anxiety? What mechanisms have you worked out with them to cope with this?  What 
mechanisms have they shared with you that helped them overcome it? Can you 
describe how you handle clients with depression or anxiety?  Have you had clients 
share with you dependence on alcohol or other drugs as a result of their depression or 
anxiety?  
 3.7 Can you speak broadly about your personal challenges and triumphs in helping 
your clients adhere? Can you share an account of challenges and triumphs of some of 
your clients in their adherence journey? What do you know about the experiences, 
views and practices of other providers? 
 3.8 In practice, what are the experiences of your clients concerning their support 
systems/ people/ family/work or union colleagues in their adherence journey?  How 
much information about their status and orientation do they share with these trusted 
people? What do you think about this? What role do you think health providers play 
in this regard? 
 3.9 What kind of relationship ties do they have with these people (are they close 
family members, partners?)   How do you think this has helped them adhere or not? 
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 3.10 Describe how your clients speak about openness to their partner/s on their HIV 
status and progress in treatment and how this may have affected how they adhere or 
not. 
   3.11 Do your clients cite openness to parents, siblings, other family as helpful to 
their adherence? If they do, what reasons do they give for how this is a positive 
influence on their adherence? 
   3.12 Do your clients speak about friends as support systems and even some friends 
who are also living with HIV and how they mutually support themselves? How do 
they describe these relationships and how this allow them adhere? 
 
Topic Area4-Societal and economic factors 
 
   4.1 Based on your close contact to your clients, what is your perception about the 
portrayal of HIV status in society/ public and how this affects their adherence to 
ART? What is your take on media campaigns and their effect on your clients adhering 
or not? 
   4.2 Can you speak about clients using other unprescribed drugs/ concoctions along 
with their ART drugs. How do you deal with this and what are their motivations for 
using other drugs or remedies in your experience?  
    4.3 Amongst the clients assessing services at this Clinic, have you noticed any kind 
of trend around demographics in relation to adherence (race, age, socioeconomic 
position)? Please explain. Probes: what role does financial stability play in your 
clients’ adherence to ART? 
    4.4 Can you describe how your clients explain the impact of their personal living 
conditions on their adherence? (Probe for shared living conditions (with parents/ 
partner/ friends) and how this affects adherence; Probe for mobility and fixed status. 
Are they moving around constantly, how does this affect adherence.) 
4.5 What do you think helped your clients in returning to taking their treatment at this 
clinic. (Probes: How did tracing them go? How easy or difficult was it for you or 
other providers to get them to come back? What were the challenges and facilitators? 
How do you think they are finding things now?( easy, difficult in between, why) 
 
 
WHEN FINISHED: 
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Thank you for your time and open discussion on such sensitive issues. I really appreciate 
it. 
Is there any question(s) you will like to ask me or anything you will like to discuss with 
me? 
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APPENDIX 7: Ethics Approval UWC 
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APPENDIX 8: Letter of Approval SACTWU 
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